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ABSTRACT 
 
 
Apoptotic and Epigenetic Induction of Embryo Failure 
Following Somatic Cell Nuclear Transfer 
 
by 
 
Aaron Patrick Davis, Doctor of Philosophy 
Utah State University, 2013 
 
Major Professor: Dr. Kenneth L. White 
Department: Animal, Dairy, and Veterinary Sciences 
 
 
Somatic cell nuclear transfer (SCNT) is a useful tool for selective breeding, 
conservation, and production of transgenic animals.  Despite the successful cloning of 
several species, high rates of embryo failure following SCNT prevent the wide-scale use 
of the technique.  Embryos produced through cloning have a higher incidence of 
developmental arrest, decreased developmental potential, frequent implantation failures, 
and increased incidence of abortion.  The objective of this dissertation research was to 
characterize the factors that lead to SCNT failures by examining epigenetic and apoptotic 
pathways that can negatively influence the development of cloned preimplantation 
embryos.   
Aberrant genome reprogramming is generally considered to be a key factor in the 
failure of SCNT embryo development.  Therefore, we used bisulfite pyrosequencing 
technology to compare DNA methylation patterns of several genes critical for embryonic 
	   	  
	  
iv 
development (POU5F1, NANOG, SOX2, and KLF4) in SCNT and in vitro fertilized 
(IVF) blastocyst stage embryos.  The methylation profiles obtained from these 
experiments indicate that methylation patterns of the POU5F1 gene were 
undermethylated compared to IVF embryos, suggesting reprogramming did occur, but 
that the reduced methylation was inappropriate for the blastocyst stage.  Furthermore, 
aberrant methylation profiles were detected for SOX2 and NANOG, suggesting that 
problems of genome reprogramming following SCNT can be gene-specific or localized.   
Because high rates of apoptosis are associated with failure of preimplantation 
embryos, we compared the activation of the P53-mediated apoptosis pathway in 
individual IVF and SCNT preimplantation embryos at multiple developmental stages.  
This pathway is activated in response to cell stress and genomic instability, and in 
response to the expression of genes associated with somatic cell reprogramming.  
Evidence from gene expression and immunohistochemistry analyses suggests that the 
P53 pathway is frequently active in SCNT embryos.  Also, we detected expression of 
several factors known to induce apoptosis more frequently and at higher levels in SCNT 
embryos. 
Collectively, the work presented here illuminates some of the molecular 
consequences of incomplete or inappropriate genome reprogramming in cloned embryos.  
The identification of these factors may lead to interventions that target the apoptosis 
pathway during preimplantation development and increase SCNT success rates.   
(183 pages) 
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PUBLIC ABSTRACT 
 
 
Apoptotic and Epigenetic Induction of Embryo Failure 
Following Somatic Cell Nuclear Transfer 
 
by 
 
Aaron Patrick Davis, Doctor of Philosophy 
Utah State University, 2013 
 
Major Professor: Dr. Kenneth L. White 
Department: Animal, Dairy, and Veterinary Sciences 
 
 
The cloning of domestic species has tremendous potential, as the technology can 
be used in selective breeding, conservation, and the production of transgenic animals.  
The technique of cloning involves the transplant of DNA from a cell to a recipient 
gamete.  Following transfer to a surrogate, the cloned embryo may successfully complete 
development to a live offspring.  Despite intensive research, the success rate of cloning 
remains prohibitively low, and the potential benefits of cloning have not yet been 
realized.  Embryos produced from cloning suffer from high rates of embryo degradation, 
implantation failure, and abortion.  The goal of this dissertation research project was to 
determine the mechanisms that cause the high rates of embryo failure in clones. 
In order for embryo development to occur properly following cloning, the donor 
cell genome must undergo epigenetic reprogramming, a process that resets the donor 
nuclei to an embryonic state.  Epigenetic markings alter the expression of genes within a 
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cell, and are one factor that prevents cells from reverting back to a primordial state.  As 
part of this research, we measured methylation of DNA, a type of epigenetic mark, to 
determine the level of reprogramming that occurs in cloned embryos.  Our results 
demonstrate that cloned embryos have abnormalities in reprogramming following cloning 
for some important genes.  This observation provides further support for the notion that 
the inefficiency of the cloning process may be a result of the inability of donor cells to 
readily reactivate genes that have been epigenetically silenced.   
A second area of research into the causes of cloning failure was to examine the 
role of programmed cell death within cloned embryos.  Every cell contains an innate 
defense system that triggers programmed cell death when the cell is under severe stress or 
has undergone irreparable DNA damage.  We observed increased incidence of 
programmed cell death in cloned embryos that contributes to the high rates of 
developmental failure.  These findings may potentially allow therapeutics targeted at 
preventing cell death, and thereby increase the success of cloning.   
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CHAPTER 1 
 
REVIEW OF LITERATURE 
 
 
History of Somatic Cell Nuclear Transfer 
 The technique of somatic cell nuclear transfer (SCNT) was originally conceived 
in the early twentieth century by developmental biologist Hans Spemann, who sought to 
understand the process whereby somatic cells specialize during development.  During this 
time he proposed an experiment in which a somatic cell would be transferred to an 
enucleated oocyte in order to determine the developmental potential of somatic cells.  
Although he lacked the appropriate instrumentation to carry out such an experiment, 
Spemann is credited with introducing the experimental design now known as SCNT.   
 Prior to Spemann’s proposed nuclear transfer experiment, Hans Driesch had 
demonstrated that each cell of an embryo contained the entire complement of genes 
necessary to carry out development.  He accomplished this by separating individual 
blastomeres from developing sea urchin embryos and observed that each blastomere had 
the capacity to develop into a separate embryo (Spemann, 1938).  This evidence was 
contrary to a competing hypothesis specifying that genes were segregated during 
development, and that the unique complement of genes found in an individual cell 
resulted in the unique phenotype of the somatic population.  Using frog embryos, 
Spemann carried out a similar set of experiments in which early-stage embryos were 
artificially split resulting in two identical embryos, each capable of carrying out 
development (Spemann, 1938).  Collectively, the work of Dreisch and Spemann affirmed 
the hypothesis of complete genome replication, although their experiments were 
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restricted to early-stage blastomeres.  The hypothesis that somatic cells lost genes during 
development could not be directly tested for several years until the instrumentation 
required for the nuclear transfer experiment originally devised by Spemann was 
developed. 
The first experiment to use nuclear transfer as a technique was completed in 1952.  
The North American leopard frog (Rana pipens) was utilized for nuclear transfer using 
late blastula cells as a donor cell source (Briggs and King, 1952).  The successful cloning 
of a frog affirmed the concept of nuclear equivalence, showing that genetic material was 
not lost during development and demonstrating that a differentiated nucleus could return 
to an undifferentiated state.  Briggs and King eventually expanded their work to include 
different donor cell types to determine whether or not all cells have the same potential for 
dedifferentiation (King and Briggs, 1955).  Further experiments showed that cloning 
efficiency declined in proportion to the degree of differentiation.  Although the success 
rate was low, late gastrula cells could be used as a donor source to successfully generate 
tadpoles (Briggs and King, 1960).  Building on these studies, Gurdon demonstrated that 
epithelial cells derived from early Xenopus tadpoles could be used as a source of donor 
cells to generate clones (Gurdon, 1962).  In a later study, Gurdon successfully used 
keratinocytes from adult Xenopus as donor cells (Gurdon et al., 1975).  While these 
experiments produced tadpoles, neither group was successful in generating adult frogs 
from cloning experiments. 
In 1975, Bromhall was the first to apply the cloning procedure to mammals.  
Using rabbits, he observed that cell divisions could occur following nuclear transfer, 
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although development never continued beyond early cleavage stages (Bromhall, 1975).  
Using enucleated mouse zygotes as recipients for zygotic nuclei, McGrath and Solter 
generated mouse offspring that developed completely to term (McGrath and Solter, 
1983).  However, subsequent cloning attempts that used mouse blastomeres as a donor 
source failed to generate embryos that could initiate development (McGrath and Solter, 
1984).  Eventually, the cloning of domestic species using blastomeres as donor cells 
resulted in the birth of clones (Willadsen, 1986; Prather et al., 1987; Prather et al., 1989).  
Each successful cloning attempt used enucleated oocytes as donor cell recipients, rather 
than zygotes which had failed to produce clones in mice (McGrath and Solter, 1984).  
Willadsen successfully generated cloned cattle using blastomeres as donor cells 
(Willadsen et al., 1991), and Sims and First successfully cloned four calves from inner 
cell mass (ICM) cells that were briefly cultured in vitro prior to use as a donor cell (Sims 
and First, 1994).   
The work of Sims and First established the use of cultured cells in SCNT 
procedures to generate mammalian offspring, but the benchmark of generating a cloned 
offspring derived from a somatic cell had yet to be achieved.  Following several failed 
attempts, it was unknown if somatic nuclei were capable of being reprogrammed to an 
undifferentiated state.   
In 1996, a research team produced a sheep cloned from the mammary epithelial 
cell of an adult sheep (Wilmut et al., 1997).  Dolly, the offspring of these experiments, 
represented a major scientific breakthrough, as the cloned ewe was the first mammalian 
offspring produced from a somatic cell.  Her birth indicated that somatic cells were, in 
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fact, capable of dedifferentiation to a totipotent state and could sustain embryo 
development following transfer to an oocyte.  Since the birth of Dolly, several somatic 
cell lines have been used for SCNT in mice, including terminally differentiated cells 
(Wakayama et al., 1998; Hochedlinger and Jaenisch, 2002). 
To date, many species have been cloned from embryonic and/or somatic cell 
lines, including: sheep (Wilmut et al., 1997), cattle (Cibelli et al., 1998a; Kato et al., 
1998; Wells et al., 1999; Kato et al., 2000), goat (Baguisi et al., 1999; Keefer et al., 
2001), pig (Betthauser et al., 2000; Onishi et al., 2000; Polejaeva et al., 2000), mouse 
(Wakayama et al., 1998; Wakayama and Yanagimachi, 1999; Hosaka et al., 2000), 
monkey (Mitalipov et al., 2002), gaur (Lanza et al., 2000b), mouflon (Loi et al., 2001), 
cat (Shin et al., 2002; Gomez et al., 2004), rabbit (Chesne et al., 2002; Challah-Jacques et 
al., 2003), zebrafish (Lee et al., 2002), rat (Zhou et al., 2003), mule (Woods et al., 2003), 
horse (Galli et al., 2003; Hinrichs et al., 2006), water buffalo (Suteevun et al., 2006), dog 
(Lee et al., 2005), banteng (Sansinena et al., 2005), ferret (Li et al., 2006), deer (Berg et 
al., 2007), pyrenean ibex (Folch et al., 2009), and camel (Wani et al., 2010).  
Additionally, human embryos have been produced by SCNT, but have not been allowed 
to develop past the blastocyst stage (Hwang et al., 2004; Tachibana et al., 2013). 
 All SCNT experiments have used variations of the first procedure established by 
Briggs and King.  Oocyte enucleation is achieved through the removal of the pronucleus 
along with the metaphase spindle.  Briggs and King performed transfer of the donor 
nucleus by aspirating the blastomere into a narrow micropipette that ensured the cell 
membrane was sheared, while leaving the nucleus intact, and then microinjecting the 
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nucleus into the oocyte (Briggs and King, 1952).  Amphibian eggs do not require any 
form of oocyte activation beyond microinjection.   
The SCNT technique is similar for mammals and amphibians, although cell fusion 
via electrofusion is preferred to microinjection for introduction of the donor cell to the 
mammalian recipient oocyte.  However, microinjection of the donor cell nucleus remains 
the standard practice in the mouse, as murine oocytes tend to self-activate upon 
stimulation with an electric pulse (Wakayama et al., 1998).  For the electrofusion 
procedure, the zona pellucida and oocyte membrane are pierced, and the first polar body, 
pronuclei and metaphase plate are removed.  The donor cell, which is similar in size to 
the polar body, is then inserted between the oocyte membrane and zona pellucida.  
Electrofusion is used to fuse the two membranes.  The cloned embryo is briefly cultured 
in vitro, then transferred to a surrogate for fetal development.  In procedures using bovine 
oocytes, activation is initiated using the calcium ionophore compound ionomycin along 
with cycloheximide to briefly suspend protein synthesis.   
Cloning has been a valuable tool for advancing science in several areas of biology 
including nuclear differentiation, nuclear reprogramming, genomic imprinting, and 
cellular aging.  Many researchers have taken advantage of genetic engineering techniques 
to manipulate the donor cell genome and subsequently perform SCNT to produce 
transgenic offspring.  One such example was the generation of a transgenic sheep that 
produced human clotting factor IX in its milk as a pharmaceutical for treatment of 
hemophilia (Schnieke et al., 1997).  Cloning has been used to generate transgenic animals 
by random gene addition (Schnieke et al., 1997), gene knockout (McCreath et al., 2000), 
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and gene mutation (Rogers et al., 2008).  Aside from the production of human proteins in 
transgenic cloned animals, SCNT also provides researchers the opportunity to modify an 
animal’s genome to reproduce desired genetic traits, such as increased casein content in 
the milk of transgenic cattle (Brophy et al., 2003) or the removal of antigens for potential 
xenotransplantation (Lai et al., 2002; Phelps et al., 2003).  Transgenic clones can also be 
used for research into human disease (Denning et al., 2001). 
 Cloning can also be applied for animal reproduction.  SCNT can be used to 
reproduce genetically superior animals as well as for the preservation of endangered 
species.  Some endangered species have been cloned for this purpose, such as gaur 
(Lanza et al., 2000b), mouflon (Loi et al., 2001), banteng (Sansinena et al., 2005), and 
water buffalo (Suteevun et al., 2006).  This procedure has also been used to clone an 
extinct species.  The pyrenean ibex, a species that went extinct in 2000, was cloned in 
2009 using cells frozen from one of the last remaining survivors (Folch et al., 2009).  
Even though the cloned animal survived throughout gestation, it died shortly after birth. 
 Cloning has also been applied in therapeutic applications including the generation 
of embryonic stem (ES) cells (Rideout et al., 2002; Barberi et al., 2003).  ES cells have 
been derived from clones in mouse (Munsie et al., 2000; Wakayama, 2003) and human 
(Hwang et al., 2004; Tachibana et al., 2013), and ES-like cells have been generated in 
cattle (Cibelli et al., 1998b) and rabbit (Fang et al., 2006).  Additionally, cloning could be 
used for pharmacology purposes, such as generating identical individuals for drug testing, 
although this potential has yet to be realized. 
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SCNT has also contributed to advances in basic biology.  Some examples include 
cloning for the study of allelic regulation (Gerdes and Wabl, 2004), the study of 
secondary rearrangements of the Immunoglobulin genes (Koralov et al., 2005), and the 
determination that olfactory receptor neurons do not generate variation through gene 
rearrangements (Eggan et al., 2004; Li et al., 2004). 
 
Limitations in Generating Cloned Offspring 
 The largest barrier to cloning is the high loss of cloned embryos during gestation.  
Most pregnancy failures occur early after implantation during the period critical to 
placental establishment (Heyman et al., 2002).  Across most species, the success rate of 
reconstructed embryos that result in the birth of healthy offspring is less than 3% 
(Thibault, 2003).  Reported success rates of various donor cells reported in Table 1-1. 
 Cloned embryos that successfully implant regularly develop placental abnormalities 
(Yang et al., 2007).  In mice, several problems associated with placental formation have 
been observed in SCNT pups (Wakayama and Yanagimachi, 1999; Tanaka et al., 2001; 
Jouneau et al., 2006; Wakisaka-Saito et al., 2006; Wakisaka et al., 2008) and similar 
observations have been made in cattle (Chavatte-Palmer et al., 2012).  An oversized and 
dysfunctional placenta is frequently observed in both aborted clones as well as those that 
have survived to term.  This abnormal placenta likely contributes to the high rates of fetal 
loss (Wakayama et al., 1998; Wakayama and Yanagimachi, 1999; De Sousa et al., 2001). 
 SCNT animals often die shortly after birth, with the most common cause of 
neonatal death thought to be respiratory distress and problems associated with circulation 
(Wilmut et al., 1997; Young et al., 1998; Hill et al., 1999).  Placental deficiencies, 
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neonatal edema, urogenital tract defects, and problems with the respiratory and 
cardiovascular systems are typical abnormalities in cloned offspring that survive to term 
(Hill et al., 1999; Renard et al., 1999; Hill et al., 2000a; De Sousa et al., 2001; Chavatte-
Palmer et al., 2002).  Reduced immunity, kidney malformation (Lanza et al., 2000a; 
McCreath et al., 2000), predisposition to infection, immature lungs, and general weakness 
(Zakhartchenko et al., 2001) are also commonly observed in cloned neonates.  In 
addition, clones often suffer from a collection of growth malformations known as large 
offspring syndrome, which is characterized by large size and a general failure to thrive 
(Young et al., 1998).  
 SCNT offspring have a much higher incidence of abnormal phenotypes than 
offspring produced in vivo or by in vitro fertilization (IVF) (Han et al., 2003; Thibault, 
2003).  The abnormal phenotypes are generally held to be the result of incomplete 
epigenetic reprogramming of the somatic cell genome after introduction into the oocyte 
(Wilmut et al., 1998; Colman, 1999; Kikyo and Wolffe, 2000; Solter, 2000; Dean et al., 
2001; Humpherys et al., 2001; Reik et al., 2001; Niemann et al., 2008).   
 
The Epigenetic Landscape 
 Epigenetics is defined as heritable changes in gene expression that are not due to 
changes to the DNA sequence.  Epigenetic factors include DNA methylation, histone 
modifications, and polycomb-trithorax complex, all of which modify the physical 
characteristics of chromatin, and lock transcriptional regions in either an active or silent 
expression state.  Epigenetic signals are stably inherited after cell division and enable 
daughter cells to recapitulate the transcriptional program of the parent cell.  The 
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development of multicellular organisms requires a specific transcriptional program of 
gene expression for each individual cell type.  In animals, over 50% of genes are inactive 
in any given cell (Bergman and Cedar, 2013)  The unique epigenetic program of each cell 
maintains both the long-term silencing of inappropriate genes and the active transcription 
of genes that are necessary to carry out the functions of the cell.  Epigenetic patterns are 
established during embryogenesis and early development and are maintained within adult 
somatic cells.   
 Epigenetic memory is maintained through methylation of DNA.  Once established, 
the pattern of methylation can be copied in each cell generation to maintain a long-term 
epigenetic signal.  Vertebrates have the highest levels of DNA methylation in the animal 
kingdom and contain methylated regions dispersed throughout most of their genomes 
(Bird, 2002).  The widespread distribution of DNA methylation patterns suggests 
methylation is involved in multiple aspects of epigenetic control (Tweedie et al., 1999).  
Researchers have postulated that DNA methylation originated as a genomic defense 
system that allowed a cell to inactivate viral and transposable elements inserted into DNA 
(Liu et al., 1994; Woodcock et al., 1997; Yoder et al., 1997; Walsh et al., 1998).  DNA 
methylation has evolved to play major roles in X-chromosome inactivation (Mohandas et 
al., 1981; Csankovszki et al., 2001), genomic imprinting (Bartolomei et al., 1993; Li et 
al., 1993; Stoger et al., 1993), the maintenance of chromosome stability (Chen et al., 
1998; Moarefi and Chedin, 2011), and possibly in RNA splicing variation (Schwartz et 
al., 2009; Laurent et al., 2010; Shukla et al., 2011).  Transcription of genes on the 
inactive X-chromosome is induced within cells treated with agents that cause global 
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demethylation (Mohandas et al., 1981; Graves, 1982; Venolia et al., 1982).  Induction of 
demethylation also causes the aberrant transcription of retroviral elements normally 
dormant within the genome (Stewart et al., 1982; Jaenisch et al., 1985).   
 DNA methylation is also involved in the long-term silencing of tissue-specific 
genes, as methylation of the transcriptional start site is associated with transcriptional 
inactivation of genes (De Smet et al., 1996; De Smet et al., 1999; Jaenisch and Bird, 
2003; Shiota, 2004; Han et al., 2011; You et al., 2011).  Embryos and cultured cells with 
reduced methylation aberrantly express a number of genes that are normally repressed 
(Stancheva and Meehan, 2000; Jackson-Grusby et al., 2001).  Some tissue-specific genes 
maintain methylation throughout development and are correspondingly transcriptionally 
inactive until a demethylation event relieves inhibition to allow gene expression (Han et 
al., 2011).  Although DNA methylation is an important mechanism for long-term 
silencing of tissue-specific genes, less than 10% of genes are regulated by DNA 
methylation (Illingworth and Bird, 2009).  Multiple tissue-specific genes undergo long-
term transcriptional inactivation without changes to DNA methylation patterns (McKeon 
et al., 1982; Bird, 1987).  However, some genes require the presence of methylation for 
long-term gene inactivation (Venolia and Gartler, 1983; Kass et al., 1997; Hashimshony 
et al., 2003). 
 In mammals, DNA methylation occurs almost exclusively on cytosine nucleotides 
in the context of CpG dinucleotides.  Approximately 75% of CpG dinucleotides are 
methylated (Ehrlich et al., 1982), most of which are concentrated in well-defined regions.  
However, any CpG dinucleotide can be methylated at any time under special 
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circumstances or in abnormal cell types, such as in cancer cells (Bird, 2002).  
Approximately 98% of CpG dinucleotides are dispersed throughout the genome at low 
density and are highly methylated.  The remaining 2% of CpG dinucleotides are in 
densely packed regions consisting of approximately one CpG dinucleotide per ten base 
pairs.  These dense clusters of CpG dinucleotides are referred to as CpG islands, and are 
generally void of methylation (Brandeis et al., 1994; Straussman et al., 2009). 
 CpG islands are a unique feature of vertebrates and are defined as regions of DNA 
with a high density of CpG dinucleotides (Illingworth and Bird, 2009).  These islands are 
associated with approximately 60% of genes and are commonly found at the 5’-end of 
genes (Antequera and Bird, 1993).  CpG islands are often associated with transcription 
factor binding regions, and methylation of these regions is linked to the transcriptional 
regulation of the associated gene (Bird, 1986; Bird, 1987; Antequera and Bird, 1993; 
Cuadrado et al., 2001; Bird, 2002; Illingworth et al., 2008).   
 Repression by DNA methylation may be weak or strong depending on the 
methylation density (Boyes and Bird, 1992; Hsieh, 1994).  Methylation of DNA leads to 
inhibition of gene expression via one of two mechanisms.  The first involves the direct 
blocking of transcription factor binding to DNA by the methyl groups attached to CpG 
dinucleotides (Prendergast and Ziff, 1991; Bell and Felsenfeld, 2000; Hark et al., 2000; 
Szabo et al., 2000; Holmgren et al., 2001).  The second, and likely more prevalent mode 
of gene silencing, involves proteins that bind selectively to methylated DNA and either 
block transcription factor access to DNA, or recruit chromatin condensation complexes 
that silence the chromatin region (Meehan et al., 1989; Jones et al., 1998; Nan et al., 
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1998; Ng et al., 1999; Wade et al., 1999; Feng and Zhang, 2001).  Several proteins have 
been discovered that selectively bind methylated DNA (Nan et al., 1993; Cross et al., 
1997; Nan et al., 1997; Hendrich and Bird, 1998).  One such protein, KAISO, has been 
found to initiate methylation-dependent repression upon binding to methylated DNA 
(Prokhortchouk et al., 2001).  Furthermore, histone deacetylases can be recruited to 
methylated DNA in order to further reinforce repression (Wade and Wolffe, 2001; Lin et 
al., 2007).   
 The family of DNA methyltransferases (DNMT) (Bestor, 1992; Miniou et al., 1994; 
Okano et al., 1998a,b; Pradhan et al., 1999; Hansen et al., 2000; Kondo et al., 2000; Rhee 
et al., 2000) is responsible for establishing and maintaining patterns of DNA methylation.  
DNMTs are essential for normal development (Li et al., 1992; Okano et al., 1999).  Both 
mice and humans with deficiencies in DNMT lack methylation on the inactive X-
chromosome and pericentromeric repetitive DNA sequences and express genes that are 
normally inactive (Bestor, 2000; Sado et al., 2000; Stancheva and Meehan, 2000).  
During DNA replication, DNMTs associate with the replication machinery to duplicate 
methylation patterns in newly synthesized DNA (Leonhardt et al., 1992).  In addition to 
DNMTs, methylation requires a number of accessory proteins that likely give DNMTs 
access to heterochromatic regions (Gibbons et al., 2000; Dennis et al., 2001).  The de 
novo establishment of DNA methylation can be targeted to CpG islands by a RNA-
directed mechanism (Wassenegger et al., 1994; Bender, 2001; Matzke et al., 2001).  
DNMTs are also attracted to specific genomic regions (Turker, 1999) by modified 
histone H3 proteins in chromatin (Tamaru and Selker, 2001), and by histone modifying 
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complexes that recruit DNMTs to condensed regions (Feldman et al., 2006; Epsztejn-
Litman et al., 2008). 
 DNA methylation does not directly stop gene transcription in actively expressed 
genes, but rather acts as a secondary mechanism that locks in a transcriptionally silent 
state after the region has been rendered transcriptionally inactive by some other 
mechanism (Gautsch and Wilson, 1983; Niwa et al., 1983; Lock et al., 1987; Keohane et 
al., 1996; Pannell et al., 2000; Wutz and Jaenisch, 2000).  Transgenes that contain a CpG 
island can maintain active transcription following genome insertion.  However, in the 
event that promoter function is impaired, DNA methylation will accumulate upon the 
transgene and prevent future expression (Macleod et al., 1994).  Aberrant de novo 
methylation, such that occurs in cancer, primarily accumulates on regions after they have 
become transcriptionally inactive.  This reinforces the view of DNA methylation as a 
‘lock’ rather than a trigger (Ohm et al., 2007; Widschwendter et al., 2007; Gal-Yam et 
al., 2008).  However, the role played by DNA methylation in maintaining silencing is 
essential for eliminating plasticity and preventing a cell from reverting back to a less 
differentiated state (Wareham et al., 1987; Epsztejn-Litman et al., 2008).  
 The distribution and extent of DNA methylation varies among species.  
Caenorhabditis elegans lacks detectible cytosine methylation or DNMT expression (Bird, 
2002).  Drosophila melengaster contains a DNA methyltransferase (Hung et al., 1999; 
Tweedie et al., 1999) and maintains low levels of DNA methylation, primarily in CpT 
dinucleotides (Gowher et al., 2000; Lyko et al., 2000).  Both of these species maintain 
epigenetic memory predominantly through the Polycomb/Trithorax Group Complex (Pc-
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G/trx-G) (Paro et al., 1998; Pirrotta, 1999; Francis and Kingston, 2001).  Pc-G/trx-G is a 
multiprotein complex that establishes a transcriptional state at targeted genomic regions 
and stably maintains either an active or repressive state of chromatin throughout 
development.  The Pc-G/trx-G achieves a similar outcome as DNA methylation in 
mammals (Yoder et al., 1997; Birchler et al., 2000).  Although mammals also utilize the 
Pc-G/trx-G system, they appear to have evolved a more complex use of DNA 
methylation that is utilized in conjunction with the Pc-G/trx-G system (Sado et al., 2000; 
Wang et al., 2001).   
 
DNA Methylation and Somatic Cell Nuclear Transfer 
 Modest improvements to cloning efficiencies have been achieved by manipulating 
factors such as SCNT activation procedure, donor cell passage number, culture 
conditions, and cell cycle stage.  Changes in these factors have been shown to alter gene 
expression in SCNT embryos (Wrenzycki et al., 2001).  However, developmental success 
still remains diminished compared to in vivo and IVF-produced embryos, likely because 
the problems associated with clones are epigenetic in nature. 
DNA methylation establishes chromatin structure required for successful 
development (Hashimshony et al., 2003).  Failure to maintain a suitable methylation 
program leads to multiple developmental abnormalities, as embryos deficient in DNA 
methylation can either fail to develop or abort during early gestation (Bestor, 2000; Bird, 
2002).  The establishment of DNA methylation patterns is a complex, coordinated 
process that occurs progressively throughout development.  Following fertilization, the 
paternal pronucleus undergoes active demethylation that occurs by enzymatic removal of 
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methyl groups from CpG sites.  This process occurs exclusively on the paternal genome 
and is completed prior to the DNA replication at the first cleavage division (Mayer et al., 
2000; Oswald et al., 2000).  The maternal pronucleus does not undergo active 
demethylation.  Instead, DNA methylation levels are gradually diluted through cleavage 
divisions, due to inhibition of methylation on the nascent DNA strand (Reik et al., 2001; 
Santos et al., 2002).  The result is global demethylation during preimplantation 
development during which methylation levels drop approximately 30% following 
fertilization (Monk et al., 1987; Kafri et al., 1992).  Demethylation as part of embryonic 
development likely occurs to remove any methylation marks imposed during 
gametogenesis (Smith et al., 2012) as well as to remove methylation patterns from 
developmentally significant genes that may be methylated in the sperm (Farthing et al., 
2008).  By the time the embryo develops to the morula stage, methylation is primarily 
found in imprinted genes and repetitive elements (Sanford et al., 1987; Walsh et al., 
1998; Reik and Walter, 2001).  However, upon cellular differentiation at the blastocyst 
stage, new methylation patterns begin to be established, and clear differences in 
methylation signature can be seen between the trophectoderm and inner cell mass (ICM) 
(Turker, 1999; Santos et al., 2002).   
A major challenge in reprogramming a somatic cell during SCNT is that 
reprogramming of donor cell methylation patterns must recapitulate the removal and 
reestablishment of methylation patterns that occur in normal embryos.  Clones must 
epigenetically reset genes required for embryo development prior to the maternal-to-
embryo transition, after which developmental progress is dependent on the transcriptional 
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program of the donor cell genome.  Several studies have observed abnormal levels of 
DNA methylation in cloned embryos (Dean et al., 1998; Dean et al., 2001; Kang et al., 
2001; Ohgane et al., 2001; Kang et al., 2002).  The mechanism responsible for the 
abnormalities in methylation patterns following SCNT is not clear, but it is likely that the 
donor cell genome responds differently to the oocyte cytoplasm than the pronucleus.   
Examples of methylation defects in clones include errors in X-chromosome 
inactivation (Keohane et al., 1996; Eggan et al., 2000; Xue et al., 2002; Senda et al., 
2004; Nolen et al., 2005), irregularities in the methylation patterns of imprinted genes and 
their expression patterns (Humpherys et al., 2001; Inoue et al., 2002; Mann et al., 2003), 
dysregulation of DNMTs (Chung et al., 2003), and overall abnormalities in patterns of 
DNA methylation (Bourc'his et al., 2001; Dean et al., 2001; Humpherys et al., 2001; 
Kang et al., 2001). 
Analysis of the organs of cloned neonate mice reveals that a large number of 
genes are aberrantly methylated (Ohgane et al., 2001; Humpherys et al., 2002).  In 
addition to alterations in DNA methylation, clones exhibit unusual patterns of histone 
acetylation and methylation (Santos et al., 2003), alterations in gene expression 
(Humpherys et al., 2002), and failure to transcribe key developmental genes (Boiani et 
al., 2002; Boiani et al., 2003).  These abnormalities reduce the developmental potential of 
clones and likely terminate the development of many cloned embryos prior to 
implantation. 
Imprinted genes are established by methylation marks that are placed on genes 
during late stages of gametogenesis that are specific to the parent of origin (Constancia et 
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al., 1998; Tilghman, 1999).  Once disrupted, imprinting patterns cannot be reestablished 
unless cells pass through germ line (Tucker et al., 1996) as imprinted patterns are 
removed in the germ cell line and then reset prior to gametogenesis (Tada et al., 1998).  
Clones display abnormalities in most imprinted genes, and the disruption of imprints is 
linked to the overgrowth commonly seen in clones (Humpherys et al., 2001).  The large 
offspring syndrome seen in clones could be a result of abnormal patterns of imprinting 
(Constancia et al., 1998; Tilghman, 1999).  Similar overgrowth abnormalities have been 
observed in humans that harbor defects in imprinted genes, as well as in mice in which 
targeted mutagenesis has altered the expression of imprinted genes (Jaenisch, 1997).   
 Aberrations in DNA methylation also contribute to placental abnormalities 
commonly observed in clones.  Deficient placental formation has been characterized in 
SCNT sheep (De Sousa et al., 2001), cattle (Hill et al., 2000a; Chavatte-Palmer et al., 
2002), and mice (Wakayama and Yanagimachi, 1999; Tanaka et al., 2001).  Perinatal 
problems have also been observed in clones (Hill et al., 1999; Chavatte-Palmer et al., 
2002; Pace et al., 2002), and these may be the result of poor placental development.  In 
normal embryos, the trophectoderm is globally undermethylated (Monk et al., 1987; 
Santos et al., 2002).  However, in clones this pattern is reversed, with the trophectoderm 
being highly methylated globally (Bourc'his et al., 2001; Dean et al., 2001; Kang et al., 
2001; Kang et al., 2002).  The abnormal methylation and gene expression patterns in the 
trophectoderm of clones likely contribute to abnormal placental development.   
 Interestingly, the epigenetic signature of cloned embryos deviates not only from 
IVF and in vivo control embryos, but also differ significantly among cloned embryos 
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(Dean et al., 2003; Jouneau and Renard, 2003; Kang et al., 2003; Santos et al., 2003; 
Hochedlinger et al., 2004).  This observation suggests that methylation patterns following 
SCNT are established stochastically.  The random patterns of epigenetic marks most 
likely contribute to the aberrant patterns of gene expression (Ohgane et al., 2001; 
Humpherys et al., 2002). 
 Further evidence that cloning failure is largely epigenetic in nature is that the types 
of epigenetic abnormalities in cloned species, at least among farm animals, are not seen 
in the offspring of clones (Tamashiro et al., 2002; Jaenisch, 2004).  Offspring born to 
clones are normal and do not exhibit any of the developmental abnormalities or high 
abortion rates associated with clones, indicating that one generation is sufficient to 
reestablish normal epigenetic architecture (Zhang et al., 2004).   
 
Epigenetic Reprogramming 
Developmental failure of SCNT embryos is thought to be the result of incomplete 
epigenetic reprogramming following transfer of the somatic cell (Wilmut et al., 1998; 
Colman, 1999; Kikyo and Wolffe, 2000; Solter, 2000; Dean et al., 2001; Humpherys et 
al., 2001; Reik et al., 2001; Niemann et al., 2008).  Nuclear reprogramming refers to 
transcriptional and epigenetic modifications required to achieve totipotency.  The desired 
outcome of nuclear transfer is for the somatic nucleus to achieve the same transcriptional 
pattern as a zygotic nucleus required to successfully direct embryogenesis.  This process 
requires silencing of genes expressed in somatic cells, and expression of zygotic-specific 
genes.   
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As part of normal mammalian development, several major reprogramming events 
alter the genomic state and clear the genome of epigenetic markings as a prelude to 
development.  The first reprogramming event occurs during primordial germ cell 
formation in which imprinted genes have their methylation signatures removed, and 
differentiation is reestablished to a totipotent state as part of gametogenesis (Tada et al., 
1997; Reik and Walter, 2001).  A second reprogramming event occurs upon fertilization 
when gamete-specific marks are erased.  In addition to reprogramming associated with 
development, a partial reprogramming event is associated with cancer development, in 
which cells undergo partial dedifferentiation and the epigenetic signature is altered in 
ways that accommodate tumor development and growth.  Reprogramming can also be 
artificially induced via ectopic expression of key reprogramming factors in order to 
generate induced pluripotent stem cells (iPSC) (Takahashi et al., 2007; Yu et al., 2007). 
Reprogramming during preimplantation development is likely a dynamic process.  
Rather than setting the donor cell nuclei to a ‘zero’ state, reprogramming appears to 
continue throughout embryo development and potentially beyond.  The demethylation 
event common to both the paternal and maternal genome does not occur in a donor cell 
nucleus to the same degree (Bourc'his et al., 2001; Dean et al., 2001).  Potentially this 
difference is because gametes are in some way poised for reprogramming, whereas the 
donor nuclei are not.  Data suggest that the greater the amount of differentiation, the less 
successful is the SCNT process.  For example, in amphibians approximately 30% of 
nuclear transfer performed with blastula cells are successful, compared to only about 2% 
for differentiated cells (Gurdon and Wilmut, 2011).  A similar pattern has been observed 
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in mammals.  Less differentiated cells, such as blastomeres or fetal fibroblasts (Rideout et 
al., 2000), have greater cloning success than adult fibroblasts or terminally differentiated 
cells (Hochedlinger and Jaenisch, 2002; Eggan et al., 2004; Li et al., 2004; Inoue et al., 
2005).  Reprogramming of the oocyte genome is directed by as yet unknown factors in 
the cytoplasm.  The reprogramming capacity of oocytes diminishes shortly after cleavage 
begins.  Beyond the two to four-cell stage, the cytoplasm of blastomeres does not appear 
capable of reprogramming donor cell nuclei (Wakayama et al., 2000). 
Microarray analysis of gene expression immediately following nuclear transfer 
indicates that an overwhelming majority (95%) of genes are expressed normally in cloned 
embryos (Humpherys et al., 2002; Smith et al., 2005; Beyhan et al., 2007; Vassena et al., 
2007).  Based on this evidence, one can reason that reprogramming is largely properly 
achieved.  However, the lack of expression of a few key genes within the minority of 
non-programmed genes may be sufficient to induce abnormal development (Boiani et al., 
2002; Bortvin et al., 2003; Aston et al., 2010).   
Cloned mouse embryos derived from cumulus cells can successfully silence 
cumulus-specific genes, demonstrating the capacity for reprogramming the gene 
expression patterns of donor cell-specific genes (Tong et al., 2007).  This study only 
examined four genes, and other studies have indicated donor-specific genes maintain 
expression (Gao et al., 2003; Tong et al., 2006).  Taken together, these findings suggest 
that reprogramming occurs, although reprogramming of specific genes can be 
incomplete.  
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In amphibians it has been shown that transferred donor cells retain epigenetic 
memory.  Donor cells derived from the mesoderm, ectoderm or endoderm maintain 
expression of lineage-specific genes upon reaching the blastocyst stage in over half of 
cloned blastocysts (Ng and Gurdon, 2008).  Such studies highlight that lineage-specific 
identity of donor nuclei is retained throughout preimplantation development.  A 
comparable experiment has yet to be carried out in mammals, although a study from the 
mouse suggests that the same may hold true of mammalian cloning.  The use of myoblast 
nuclei as a donor source, followed by embryo culture in myoblast culture medium, 
triggers the expression of muscle-specific cell markers in cloned embryos (Gao et al., 
2003). 
 The successful development of cloned embryos may hinge on the proper expression 
of pluripotency factors such as POU5F1 (Boiani et al., 2002; Bortvin et al., 2003; Byrne 
et al., 2003; Armstrong et al., 2006; Lee et al., 2006) as preimplantation embryos require 
POU5F1 in order to develop (Nichols et al., 1998; Pantazis and Bollenbach, 2012).  
POU5F1 is a transcription factor that directs the expression of multiple developmental 
genes and is essential for early development (Niwa et al., 2000).  SCNT embryos fail to 
upregulate embryo-specific genes including POU5F1 (Boiani et al., 2002; Bortvin et al., 
2003; Kishigami et al., 2006).  It has been reported in some mouse studies that the use of 
ES cells as a donor source have higher cloning efficiency over somatic cells (Wakayama 
et al., 1999; Rideout et al., 2000; Eggan et al., 2001), which may be due, in part, to 
expression of POU5F1 in ES cells (Nichols et al., 1998; Pantazis and Bollenbach, 2012).   
 Exposure of donor cells to cell extracts designed to induce reprogramming prior to 
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transfer has had limited success (Landsverk et al., 2002; Hansis et al., 2004), likely 
because these agents do not discriminate against terminally silenced regions and are not 
specific to the few genomic regions that require epigenetic activation.  Recent work has 
demonstrated that injecting mouse donor cells into Xenopus eggs leads to demethylation 
of the mouse POU5F1 gene (Simonsson and Gurdon, 2004).  Such an outcome is 
unexpected, given that the Xenopus zygote does not undergo active demethylation 
(Stancheva et al., 2002).  The results suggest that a conserved, yet to be identified 
mechanism exists that is capable of genome reprogramming. 
 Genetic mutations accumulate during aging and during prolonged periods of in 
vitro culture (DePinho, 2000).  This opens the possibility that cloning failure is in part 
caused by genetic abnormalities.  However, the fact that cloning abnormalities are shared 
among all species, as well the observation that cloned animals are able to give birth to 
offspring without any mutant phenotype strongly suggests that the deficiencies in cloned 
organisms are epigenetic in nature.  It is unclear however, how much of reprogramming 
process is mediated by the oocyte environment versus the epigenetic state of the 
individual donor cell at the time of transfer (Roemer et al., 1997).   
 In cattle, no difference has been seen between cloning success using donor cells 
collected from young versus old individuals or low versus high passage fibroblasts (Hill 
et al., 2000b; Kubota et al., 2000).  However a conflicting report from sheep suggests that 
rates of cloning failure are higher with high passage number fibroblasts (Schnieke et al., 
1997; Wilmut et al., 1997; McCreath et al., 2000).  However, it is important to note that 
in these experiments, the overall success rate of any sample was extremely low, making it 
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difficult to draw statistically significant conclusions.   
 Although several examples demonstrate that cloned embryos are characterized by 
reprogramming failures a limited number of cloned offspring appear normal in all 
regards, suggesting that appropriate reprogramming can occur (Chavatte-Palmer et al., 
2002; Cibelli et al., 2002).  Additionally, some aspects of embryo development appear to 
be normal in clones.  X-chromosome inactivation occurs following the formation of the 
zygote.  X chromosomes are randomly silenced within ICM cells, but in trophoblast cells, 
an unknown imprinting mechanism causes preferential inactivation of the paternal X-
chromosome.  Cloned embryos follow a similar pattern of paternal X-chromosome 
inactivation in trophoblasts (Eggan et al., 2000), indicating that clones retain this 
hierarchical silencing process.   
 
The P53-Mediated Apoptosis Pathway 
 The transcription factor P53 plays a central role in cellular health and ensures 
genomic integrity by initiating programmed cell death within defective and aberrant cells.  
During P53-mediated apoptosis, the cell shrinks, DNA is fragmented and membrane 
blebbing occurs.  These features allow the degraded cell contents to be phagocytosed, 
thus preventing inflammation in surrounding tissue that would occur through cell death 
without apoptosis (Kerr et al., 1972).  P53 acts as a sensor to eliminate unneeded cells 
and prevent overgrowth, as well as eliminating cells under stress, with DNA damage and 
that grow uncontrollably.  Due to its role in enforcing genomic stability, P53 is 
commonly referred to as the guardian of the genome.  By preventing mitotic division of 
cells with DNA damage or oncogene expression, P53 prevents tumorigenic growth.  The 
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critical role of P53 in preventing growth of aberrant cells is clearly shown by the high 
rate and early development of tumors in P53 knockout mice (Donehower et al., 1992). 
Under normal conditions, cells maintain a constant but low level of P53 within the 
cytoplasm.  Because of its potential to terminate progression through the cell cycle, 
mechanisms that maintain P53 in an inactive form are strictly regulated.  The regulator 
MDM2 forms a negative feedback loop to prevent P53 activation by consistently 
targeting P53 for degradation, thereby preventing accumulation of P53 within the cell 
(Moll and Petrenko, 2003; Kruse and Gu, 2009). 
Activation of P53 can be induced by a variety of triggers including DNA damage, 
hypoxia, nucleotide depletion, reactive oxidative species, and oncogene activation, with 
the activation method determining the action carried out by P53.  Activation of the P53 
pathway may occur directly via various input signals, or activation can arise indirectly 
through the inhibition of MDM2 that leads to the accumulation and subsequent activation 
of P53.  Upon activation, P53 homodimerizes and translocates to the nucleus where it 
upregulates a number of genes to carry out cell cycle arrest, senescence or apoptosis 
(Vousden and Lu, 2002). 
A number of genes upregulated by P53 have been identified (Riley et al., 2008).  
Upon activation, P53 can either induce cell cycle arrest or initiate programmed cell death.  
Under normal conditions, cell cycle progression is induced by cyclin-dependent kinases 
(CDK), which are upregulated in preparation for progression through different stages of 
the cell cycle.  CDKs form a complex with cyclin which acts as an inducer for the cell 
cycle.  P21WAF1/Cip1 (CDKN1A) is upregulated by P53 (Brugarolas et al., 1999) and acts 
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by inhibiting cyclin/CDK to prevent cell cycle progression (Niculescu et al., 1998).  
Thus, P53 upregulation of P21WAF1/Cip1 induces cell cycle arrest and prevents cell 
division. 
 Aside from cell cycle arrest, activation of P53-dependent gene expression leads to 
apoptosis.  Alternatively, P53 can directly activate apoptosis in a transcription-
independent manner.  Either pathway ultimately leads to the release of cytochrome c 
from the mitochondrial membrane, which acts as a mediator of programmed cell death 
(Wei et al., 2001).  In both transcription-dependent and transcription-independent 
pathways, the downstream effects of P53 at the mitochondria involve members of the 
BCL2 family of proteins (Cory and Adams, 2002) that can either activate or inhibit 
apoptosis by controlling release of cytochrome c from the mitochondria. 
 Pro-apoptotic members of the BCL2 protein family include BAX, BAK, BID 
NOXA, and PUMA.  These pro-apoptotic proteins can be upregulated by P53 (Oltvai et 
al., 1993; Miyashita and Reed, 1995) and oligomerize to form a channel on the 
membrane of mitochondria through which cytochrome c is released (Miyashita and Reed, 
1995; Chipuk et al., 2004).  Anti-apoptotic members of the BCL2 protein family include 
BCL-2, BCL-xl, and MCL-1.  These proteins antagonize pro-apoptosis inducing proteins.  
BAX activity is inhibited by BCL2, which heterodimerizes with BAX and inhibits BAX-
mediated induction of apoptosis (Yin et al., 1994).  The BCL2:BAX ratio controls 
whether apoptosis is induced or inhibited (Basu and Haldar, 1998).  BCL2 is expressed 
continually and maintains a constant inhibition of BAX.  However, upon upregulation of 
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BAX by P53, the BCL2:BAX ratio is tipped in favor of BAX, allowing BAX to 
oligomerize and initiate apoptosis. 
The P53 pathway may also act in a transcription-independent manner to induce 
apoptosis (Caelles et al., 1994; Wagner et al., 1994; Yan et al., 1997; Gao and Tsuchida, 
1999).  Deletion of the DNA-binding domain of P53 maintains its apoptosis-inducing 
ability under certain conditions (Haupt et al., 1995; Chen et al., 1996; Haupt et al., 1997).  
When acting as a direct activator of apoptosis, P53 translocates to the mitochondria 
(Marchenko et al., 2000; Sansome et al., 2001; Mihara et al., 2003) where it initiates 
apoptosis by either the activation of pro-apoptosis proteins, or the inhibition of anti-
apoptosis proteins (Mihara et al., 2003; Tomita et al., 2006).  P53 is able to both directly 
activate BAX and to inhibit BCL2 (Wang et al., 1993; Chiou et al., 1994; Marin et al., 
1994; Froesch et al., 1999). 
The transcription-independent pathway of P53-directed apoptosis has been linked 
to apoptosis induction by reactive oxygen species (Han et al., 2008).  However, DNA 
damage response and tumor suppression requires P53 to act in a transcription-dependent 
manner (Chao et al., 2000; Jimenez et al., 2000; Johnson et al., 2005; Gaidarenko and Xu, 
2009).  In cells that undergo cell cycle arrest, P53 does not localize to the mitochondria.  
In this case, cell cycle arrest is a transcription-dependent process (Marchenko et al., 2000; 
Erster et al., 2004) and involves the upregulation of P21WAF1/Cip1. 
 Via its role in regulating apoptosis, P53 is a vital component of normal 
development and maintenance of tissue and organs.  For example, P53-null mice have a 
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high incidence of birth defects, such as polydactylism, problems in bone development, 
and abnormalities in neural tube formation (Armstrong et al., 1995).    
P53-mediated apoptosis also plays a role during preimplantation development 
(Hardy et al., 2001; Gjorret et al., 2003).  P53 prevents the integration of blastomeres 
with genetic abnormalities (Fabian et al., 2005).  Conversely, excessive accumulation of 
P53 within the developing embryo is a direct impediment to embryo viability and 
implantation (Ganeshan et al., 2010).  In mouse preimplantation embryos, decreased 
apoptosis levels result in significantly higher rates of fetal development following 
embryo transfer (Li et al., 2007).   
 Recently, P53 was revealed to play a major role in the efficiency of 
reprogramming iPSCs, as the elimination of P53 dramatically improved reprogramming 
efficiency (Zhao et al., 2008).  P53-null cell lines have dramatically higher success rates 
of reprogramming (Hong et al., 2009; Kawamura et al., 2009).  Additionally, cell lines 
that have previously failed to reprogram have been able to successfully do so following 
p53 inhibition (Utikal et al., 2009).   
The reprogramming pathway common in iPSC formation induces apoptosis, 
senescence, and cell cycle arrest.  Reprogramming causes DNA damage, which can 
activate the P53 apoptosis pathway (Marion et al., 2009).  Additionally, the 
reprogramming factors used to induce somatic cell potency also have oncogenic effects 
that likely induce apoptosis.  The six factors regularly used in reprogramming 
experiments, C-MYC, LIN28, KLF4, POU5F1, NANOG, and SOX2 (Takahashi et al., 
2007; Yu et al., 2007; Silva et al., 2009), are also involved in the induction of apoptosis.   
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C-MYC is an established oncogene that induces apoptosis when overexpressed 
(Pelengaris et al., 2002; Rowland and Peeper, 2006).  P53-null cell lines can be induced 
to become stem cells by the addition of the reprogramming factors POU5F1 and SOX2 
alone, suggesting that one function of C-MYC in reprogramming may be to select for 
cells with reduced P53 functionality (Eischen et al., 1999; Kawamura et al., 2009).  
LIN28 is a translational enhancer of various oncogenes, including C-MYC (West et al., 
2009), and its presence likely enhances C-MYC expression and increases apoptosis.  
KLF4 suppresses P53 (Rowland and Peeper, 2006), while simultaneously inducing the 
expression of P21WAF1/Cip1 to inhibit cell cycle progression (Zhang et al., 2000; Chen et 
al., 2003; Rowland et al., 2005; Rowland and Peeper, 2006).  NANOG, POU5F1, and 
SOX2 are required for potency and are overexpressed in some types of cancers (Almstrup 
et al., 2004; Ezeh et al., 2005; Hart et al., 2005; Hochedlinger et al., 2005).  P53 is 
activated by these factors either collectively (Hong et al., 2009; Kawamura et al., 2009; 
Marion et al., 2009), or individually (Kawamura et al., 2009).  Additionally, SOX2 and 
POU5F1 act to trigger cell cycle arrest by upregulating P21WAF1/Cip1 via P53 induction 
(Kawamura et al., 2009). 
 As SCNT requires reprogramming of the somatic donor cell, the activation of 
P53-mediated apoptosis may be responsible for increased cell death following somatic 
cell nuclear transfer.  However, no studies have established the expression of 
reprogramming associated genes or the upregulation of P53 targets following SCNT.  
Apoptosis has been reported to occur with higher frequency in embryos produced by 
SCNT than embryos produced by IVF (Fahrudin et al., 2002; Hao et al., 2003; Jang et al., 
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2004; Gjorret et al., 2005; Im et al., 2006; Kumar et al., 2007), and elevated apoptosis 
continues throughout development (Hao et al., 2003).  However, it is unclear if increased 
apoptosis is the result of sub-optimal culture conditions, the stress associated with the 
cloning procedure, or possibly the byproduct of donor cell reprogramming.  The cloning 
procedure may induce higher levels of apoptosis.  For example, porcine clones activated 
by electroporation alone have reduced apoptosis relative to clones activated by 
electroporation with chemical activation (Im et al., 2006). 
In addition to increased levels of apoptosis, cloned embryos have a reduced 
number of blastocyst cells that likely is due to increased apoptosis (Koo et al., 2000; 
Fahrudin et al., 2002; Gjorret et al., 2005; Terashita et al., 2011).  A reduced blastomere 
number likely results in reduced embryo viability and implantation potential (van Soom 
et al., 1997; Wuu et al., 1999).  Both apoptosis and total cell count reflect important 
developmental parameters that influence the developmental potential of preimplantation 
embryos (Brison and Schultz, 1997; Brison and Schultz, 1998; Koo et al., 2000; Knijn et 
al., 2003).  Should the reprogramming process in SCNT embryos activate P53-mediated 
apoptosis, this would suggest that the high rates of embryo failure might, in part, be the 
result of donor cell reprogramming.  
 
Summary 
 A great deal of effort by many research groups has been applied to improving the 
efficiency of SCNT.  A large body of evidence supports the hypothesis that clones suffer 
from a failure to reset the epigenetic program of the somatic donor cell.  There is also 
evidence that preimplantation SCNT embryos experience elevated levels of apoptosis, 
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which likely contributes to failed embryo development and implantation.  A separate line 
of inquiry has demonstrated that somatic cell reprogramming activates the P53 apoptosis 
pathway and induces programmed cell death in cells that are aberrantly reprogrammed 
within the somatic cell genome.  Should the same pattern of reprogramming-induced 
apoptosis occur in cloned embryos, then SCNT embryo failure may be the result of 
successful reprogramming, rather than a reprogramming failure.   
 
Research Goals and Potential Applications 
 The first objective of my dissertation was to characterize the patterns of DNA 
methylation in SCNT embryos, in order to identify the epigenetic reprogramming status 
of several important developmental genes following SCNT, and to understanding the 
regulation of DNA methylation.  The second objective was to characterize p53-mediated 
apoptosis following SCNT. 
 For the first objective, I was able to demonstrate that reprogramming is 
incomplete following SCNT, and that methylation patterns at some CpG sites in key 
genes of SCNT embryos are more similar those found in the donor cell than those seen in 
IVF embryos.  In a separate study related to DNA methylation, I characterized the 
methylation status of a family of LIN28 pseudogenes.  These studies hold the potential to 
better understand how the addition and maintenance of methylation patterns are 
regulated. 
 For the second objective, I confirmed the activation by P53-mediated apoptosis 
within SCNT preimplantation embryos, and identified several P53-activated genes that 
are upregulated in clones.  Importantly, my work demonstrated that the reprogramming 
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factors C-MYC, SOX2, KLF4, and LIN28 are upregulated in clones.  My findings suggest 
that SCNT embryos have elevated expression of reprogramming factors.  The expression 
of these factors likely activates P53, leading to increased apoptosis and cell cycle arrest in 
SCNT embryos.  These findings identify several genes that contribute to blastomere 
depletion and failed development.   
 SCNT holds immense potential in the production of transgenic animals, the 
generation of stem cells, and the production of species with superior traits.  However, all 
potential benefits are constrained by the low efficiency of the technique.  My research 
strengthens our understanding of the nature of embryo failure, and reveals potential 
interventions to inhibit apoptosis to allow SCNT with higher developmental rates.  
Additionally, my findings in the area of DNA methylation contribute to greater 
understanding of the reprogramming process and have application in several areas of 
biology, including stem cell biology, reprogramming, epigenetics, and cancer. 
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CHAPTER 2 
 
DNA METHYLATION REPROGRAMMING OF THE POU5F1, NANOG, SOX2 AND 
KLF4 GENES FOLLOWING SOMATIC CELL NUCLEAR TRANSFER 
 
 
Abstract 
Aberrant methylation patterns have been implicated as a contributing factor in the 
poor development of embryos following somatic cell nuclear transfer (SCNT).  Embryos 
produced via SCNT that are unable to epigenetically reprogram somatic cell-specific 
methylation patterns are at a developmental disadvantage, as the donor cell methylation 
signature retained within cloned embryos reinforces inappropriate gene silencing.  Using 
bisulfite sequencing, we compared multiple methylation sites in the POU5F1 (OCT4), 
NANOG, SOX2, KLF4, C-MYC, and LIN28 genes within bovine IVF and SCNT 
blastocyst embryos and donor cells.  Prior to implantation, the methylation patterns of 
NANOG and SOX2 in SCNT embryos are more similar to patterns observed in somatic 
cells than patterns seen in IVF blastocysts.  We also observed that methylation of 
POU5F1 is lower in SCNT blastocysts, suggesting that reestablishment of methylation of 
this gene prior to implantation of SCNT embryos is delayed.  Our results demonstrate 
that methylation patterns vary among developmental genes in SCNT embryos, with 
reprogramming at some CpG sites and incomplete reprogramming at others. 
 
Introduction 
Since the cloning of the first animal from somatic cells, the technique of somatic 
cell nuclear transfer (SCNT) has had limited success in embryo development and 
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production of viable offspring (Wilmut et al., 1997).  Despite intense research, the 
benefits of cloned offspring remain limited due to the failed development of embryos and 
fetuses generated via SCNT (Wells, 2005).  Following SCNT, many cloned neonates die 
shortly after birth and often exhibit phenotypic abnormalities (Hill et al., 2000a; Farin et 
al., 2004; Li et al., 2005).  SCNT-derived organisms face challenges at each stage of 
development.  The low success rate of the SCNT procedure appears to be due in large 
part to incomplete embryonic reprogramming of the somatic genome (Wilmut et al., 
1998; Colman, 1999; Kikyo and Wolffe, 2000; Solter, 2000; Dean et al., 2001; 
Humpherys et al., 2001; Reik and Walter, 2001; Niemann et al., 2008). 
 Several phenotypic abnormalities have been observed in clones, including placental 
deficiency, fetal loss, respiratory problems, and cardiovascular failure (Hill et al., 1999; 
Hill et al., 2000b; De Sousa et al., 2001; Chavatte-Palmer et al., 2002; Yang et al., 2007).  
Neonates are predisposed to infection and weakness (Zakhartchenko et al., 2001), as well 
as a condition referred to as large offspring syndrome, which is characterized by 
abnormally large body and organ size (Young et al., 1998; Farin et al., 2004).  Large 
offspring syndrome shares many similarities with human epigenetic disorders, such as 
Beckwith-Wiedman syndrome (DeBaun et al., 2003; Everts et al., 2008).  In addition, 
altered levels of gene expression have been observed in SCNT embryos (Sebastiano et 
al., 2005; Aston et al., 2010).  These abnormalities are likely due to the failure of the 
SCNT embryo to appropriately reprogram the epigenome of the donor cell nucleus to an 
embryonic state. 
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DNA methylation in mammals involves the covalent addition of a methyl group 
to the cytosine within cytosine-guanine (CpG) dinucleotides.  DNA methylation is 
responsible for the inactivation of transposons within the genome (Yoder et al., 1997), X-
chromosome inactivation (Mohandas et al., 1981; Csankovszki et al., 2001), 
establishment and silencing of imprinted genes (Bartolomei et al., 1993; Li et al., 1993; 
Stoger et al., 1993), and maintenance of chromosome stability (Chen et al., 1998).  
Additionally, DNA methylation plays a role in the silencing of gene transcription 
(Jaenisch and Bird, 2003; Shiota, 2004) through one of two mechanisms: 1) the presence 
of methyl groups in DNA directly blocks the binding of transcription factors (Watt and 
Molloy, 1988; Hendrich and Bird, 1998; Prokhortchouk et al., 2001) and 2) methylation 
of DNA targets the region for chromatin silencing that prevents gene transcription (Jones 
et al., 1998; Wade et al., 1999; Zhang et al., 1999; Sarraf and Stancheva, 2004).  
Although any CpG site within the mammalian genome can incur methylation (Bird, 
2002), CpG dinucleotides often cluster within CpG dense regions known as CpG islands 
(Illingworth and Bird, 2009).  These islands are commonly found at the 5’-end of genes, 
have a high density of CpG sites (about one site per 10 bp), and are associated with 
transcriptional start sites (Antequera and Bird, 1993).  
Abnormal levels of DNA methylation present a significant impediment to animal 
cloning.  Cloned bovine embryos have higher levels of global methylation than in vivo or 
in vitro fertilized (IVF) embryos (Kikyo and Wolffe, 2000; Kang et al., 2001).  
Additionally, specific genes have been shown to undergo gradual loss of methylation in 
cloned embryos throughout embryo development (Yamazaki et al., 2006), indicating that 
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methylation patterns of somatic cells are not correctly reprogrammed via the same 
mechanism undergone by in vivo and IVF embryos. 
The discovery of transcription factors capable of inducing pluripotency in 
differentiated cells may provide insights into the challenges of SCNT development 
(Takahashi et al., 2007; Yu et al., 2007).  Pluripotency-inducing transcription factors 
include POU5F1 (OCT-4) (Pesce and Scholer, 2001), NANOG (Chambers et al., 2003; 
Mitsui et al., 2003), SOX2 (Avilion et al., 2003), KLF4 (Evans and Liu, 2008), C-MYC 
(Adhikary and Eilers, 2005), and LIN28 (Darr and Benvenisty, 2009).  When expressed 
ectopically in various combinations, these pluripotency genes are able to fully reprogram 
somatic cells (Takahashi et al., 2007; Yu et al., 2007).  Additionally, POU5F1, SOX2, 
KLF4, C-MYC, and NANOG expression is essential for the creation of induced 
pluripotent stem cells in cattle (Sumer et al., 2011).  Either the absence or irregular 
expression of these factors likely impedes successful development following SCNT. 
To determine whether or not DNA methylation patterns in pre-implantation stage 
SCNT embryos are appropriate for embryonic development, we characterized DNA 
methylation patterns of POU5F1, NANOG, SOX2, KLF4, C-MYC, and LIN28 genes in 
bovine SCNT and IVF blastocysts and compared them to patterns observed in the donor 
cell line.  We determined that the methylation patterns of SCNT embryos are more 
similar to those of the donor cell for the NANOG and SOX2 genes.  Additionally we 
determined that the methylation patterns of CpG sites in POU5F1 were abnormally 
regulated in SCNT embryos.  The aberrant epigenetic patterns may lead to irregularities 
in gene expression patterns and restrict reprogramming in SCNT embryos. 
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Materials and Methods 
Donor Cell Culture 
Bovine fibroblasts were collected from skin samples and cultured in DMEM F12 
(Thermo Scientific HyClone Laboratories, Logan, UT) supplemented with 15% fetal 
bovine serum (FBS) (Thermo Scientific HyClone Laboratories), 100 U/ml penicillin, and 
100 mg/ml streptomycin.  Cells were seeded in T25 culture flasks and cultured at 37°C 
with 5% CO2.  Prior to SCNT cultured cells were treated with 0.25% trypsin and 
resuspended in phosphate buffered saline (PBS). 
 
Oocyte Maturation 
Cumulus oocyte complexes were aspirated from 3 to 8 mm follicles from ovaries 
collected at a local abattoir (E.A. Miller, Hyrum, UT).  Cumulus oocyte complexes were 
cultured 18 to 22 hr in TCM 199 maturation medium (Thermo Scientific HyClone 
Laboratories) containing 10% FBS, 0.05 mg/ml follicle stimulating hormone (FSH), 5 
mg/ml luteinizing hormone (LH), 100 U/ml penicillin, and 100 mg/ml streptomycin. 
 
In Vitro Fertilization 
Following 18 to 22 hr of oocyte maturation, cryopreserved bovine semen 
(Hoffman AI, Logan, UT) was thawed and live sperm were collected via centrifugation 
with a 45%/90% percoll gradient.  Live sperm were suspended in Tyrode’s albumin 
lactate pyruvate (TALP) to be used for oocyte fertilization.  Twenty-four hours following 
fertilization, cumulus oocyte complexes were vortexed in PBS with 0.32 mM sodium 
pyruvate, 5.55 mM glucose, 3 mg/ml BSA, and 10 mg/ml hyaluronidase to remove 
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cumulus cells from the oocyte.  Oocytes were subsequently washed with PBS and 
cultured in CR2 medium atop a layer of cumulus cells.   
 
SCNT Production 
Cumulus cells were removed following maturation as described above.  
Metaphase II oocytes with an extruded first polar body were selected as recipient 
cytoplasts.  Following enucleation, removal of the metaphase plate and polar body, a 
single donor cell was placed in the perivitelline space.  Oocyte and donor cell fusion was 
carried out with two electric DC pulses of 2.2 kV/cm for 25 µsec applied to embryos 
placed in a fusion chamber suspended in mannitol fusion medium (Wells et al., 1999).  
Following fusion, embryos were placed in CR2 medium for 1 to 3 hr prior to activation.  
Embryo activation was performed 23 to 25 hr following maturation of oocytes by 
treatment with 5 mM ionomycin for 5 min and 10 mg/ml cyclohexamide for 5 hr.  
Activated embryos were then placed in co-culture dishes with CR2 medium atop a layer 
of cumulus cells.   
 
Bisulfite Conversion 
A pool of 25 SCNT or IVF embryos was collected over the course of 3 IVF or 
cloning sessions.  Embryos were collected on day eight of development, and embryos of 
similar size and quality were selected.  Following collection embryos were snap frozen 
with liquid nitrogen and stored at -80°C until direct bisulfite conversion.  Approximately 
1 million donor cells were collected and DNA was isolated using the DNeasy Blood and 
Tissue Kit (Qiagen, Germantown, MD) and 1 µg of DNA was used for bisulfite 
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conversion.  Embryos were used directly for bisulfite conversion.  Bisulfite conversion 
was carried out using the EZ DNA Methylation Kit (Zymo Research, Irvine, CA) 
according to the manufacturer’s protocol.  Converted DNA was immediately used in PCR 
reactions. 
 
PCR and 454 Sequencing 
Following bisulfite conversion, converted embryo pools or donor cell DNA were 
used as template in 25 µl PCR reactions using 1 to 3 µl bisulfite converted genomic DNA 
with 0.6 µM primers in GoTaq Master Mix (Promega, Madison, WI) reactions.  The 
same cycling parameters were used for all primer pairs: 94°C for 1 min, annealing 
temperature ranging from 54 to 59°C for 20 sec, and 72°C for 30 sec for 30 cycles.  A 
second PCR was performed using identical primers including the 454 adapter and key 
sequence (adapter A CCATCTCATCCCTGCGTGTCTCCGACTCAG on the forward 
primer and adapter B CCTATCCCCTGTGTGCCTTGGCAGTCTCAG on the reverse 
primer).  This second round of PCR used 1 to 3 µl of the PCR product from the first 
round and 0.3 µM primer in GoTaq Master Mix (Promega) and the following cycling 
parameters: 94°C for 30 sec, annealing temperature ranging from 55 to 60°C for 20 sec, 
and 72°C for 30 sec for 15 cycles.  After purification with AMPure beads (Beckman 
Coulter, Brea, CA) and quantification with PicoGreen (Life Technologies, Carlsbad, 
CA), PCR products were pooled and finally sequenced on the 454 GS FLX Titanium 
DNA sequencer (Roche, Indianapolis, IN) according to the manufacturer’s protocols.  
Briefly, amplicon libraries were subjected to emulsion PCR to produce DNA-coated 
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beads, loaded onto a 70X75 PicoTiterPlate, and sequenced using the FLX Titanium DNA 
sequencing Kit.   
 
Sequence Analysis 
Sequencing data was analyzed for frequency of methylation using BISMA 
analysis software (Rohde et al., 2010).  Data are expressed as the percentage of 
methylated CpG sites by normalizing methylation frequency data to the number of 
sequence reads obtained. 
 
Statistical Analysis 
 To determine whether methylation levels were significantly different among 
donor cells, IVF, and SCNT embryos, we performed Fisher’s exact tests on a per CpG 
site basis using the number of methylated transcripts and the number of unmethylated 
transcripts in a categorical analyses; thus, these tests are influenced by the total number 
of transcripts obtained for each amplicon.  The resulting raw P values were then 
Bonferroni-adjusted using proc multtest (SAS 9.3, Cary, NC) to account for multiple 
testing.   
 
Results 
 DNA methylation patterns were examined using bisulfite sequencing of 336 CpG 
sites at single base pair resolution across six genes.  DNA methylation within the donor 
cell line was observed in the POU5F1, NANOG, and SOX2 genes, whereas limited 
methylation was observed within the gene body of KLF4.  The LIN28 and C-MYC genes 
had no methylation within any of the regions examined and were excluded from further 
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analysis.  Once the donor cell methylation patterns were examined, patterns of POU5F1, 
NANOG, SOX2, and KLF4 within IVF and SCNT blastocyst stage embryos were 
examined.  This analysis revealed aberrant methylation of DNA within SCNT embryos. 
 
Methylation of POU5F1 
Analysis of the POU5F1 CpG island revealed an island beginning immediately 
upstream from the translation start site that spans the entirety of the first exon (Fig. 2-1).  
The methylation status of the POU5F1 CpG island is summarized in Figure 2-2.  Overall, 
54% of the CpG sites were methylated within this region.  Interestingly the methylation 
levels were not uniform across the length of the CpG island, as relatively low methylation 
was detected at the 5’ end and comparatively high methylation at the 3’ end of the 
examined sequence.  Overall methylation in IVF embryos was low, with 35% of all CpG 
sites methylated.  Methylation in bovine SCNT embryos was substantially lower than 
both donor cells and IVF blastocysts, with 18% of all CpG sites methylated (Fig. 2-2).   
A statistical comparison of these methylation profiles revealed specific CpG sites 
that are differentially methylated.  CpG site 4 is among the most frequently methylated 
sites in the donor cell line (Fig. 2-2).  Seventy-one percent of donor cell sequence reads 
are methylated, compared to 49% in IVF embryos.  By contrast, none of the SCNT 
sequence reads were methylated at this site.  Similar observations were observed at sites 
26 and 40, all of which were differentially methylated in SCNT embryos and donor cells 
(Fig. 2-2).  These CpG sites appear to have undergone successful reprogramming within 
the SCNT genome, although based on methylation patterns observed within IVF samples, 
the reduction of methylation levels appears to be inappropriate for the blastocyst stage.  
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In SCNT embryos, methylation at the 3’ end of the CpG island is more prevalent 
compared to the 5’ end, although methylation of this 3’ region remains lower than levels 
detected in IVF embryos.  Of note, methylation at CpG sites 140, 164, and 263 is 
significantly different lower in SCNT embryos compared to IVF embryos or to donor 
cells (Fig. 2-2).  At a number of other CpG sites in this 3’ region, methylation levels are 
significantly different among all sample types (e.g., sites 232, 250, 284, 320, 355). 
When considering the entire CpG island, average methylation levels are highest in 
donor cells (54%), lower in IVF embryos (35%), and lowest in SCNT embryos (18%).  
However, three closely aligned CpG sites break from this apparent pattern.  Specifically 
CpG dinucleotides at sites 56, 64, and 79 are more frequently methylated in SCNT 
embryos than IVF, yet methylation at these sites is lower in both embryo types compared 
to donor cells (Fig. 2-2). 
 
Methylation of NANOG 
NANOG contains a small CpG island within the first intron that begins 270 bp 
downstream from the transcription start site (Fig. 2-1).  The methylation status for this 
region is summarized in Figure 2-3.  Within this region, some SCNT CpG sites more 
closely resemble the methylation pattern of the donor cell, while others are more similar 
to IVF.  The overall average DNA methylation for this region is higher in the SCNT 
samples than donor cell as well as IVF.  Within the donor cell samples, 25% of CpG sites 
are methylated; in IVF blastocysts, 21% of CpG dinucleotides are methylated; and within 
SCNT blastocysts, 31% of CpG sites are methylated (Fig. 2-3).  Results of the statistical 
analyses of methylation frequency were not significant for any particular CpG site, likely 
	   	  
	  
72 
72 
a consequence of the low number of sequence reads obtained.  Even so, it is interesting to 
note that for seven CpG loci, methylation is completely absent in IVF embryos, while 
several of these sites (e.g., 303, 308, 487) are moderately methylated in SCNT embryos 
and donor cells.  Only one site was not methylated in SCNT embryos, while every CpG 
locus examined was methylated to some extent in donor cells. 
Another interesting feature of the examined region in NANOG was an apparent 
spike in the percentage of methylated cytosines at CpG site 523.  A methylation spike is 
defined here as a sharp elevation in the methylation of a CpG dinucleotide that is closely 
associated with other CpG loci that retain low levels of methylation.  Within the NANOG 
CpG island site 523 was methylated at a percentage of 83% in SCNT embryos, 70% in 
donor cells, and 55% in IVF embryos (Fig. 2-3). 
 
Methylation of SOX2 
SOX2 is a single exonic gene and contains a 3000 bp CpG dense region that 
begins 1500 bp upstream from the transcriptional start site and continues throughout the 
gene.  Three CpG islands were identified within this region, and several CpG sites were 
examined for methylation (Fig. 2-1).  Our analysis identified two regions that were 
positive for methylation within donor cells, and both regions were subsequently 
examined for methylation patterns within IVF and SCNT embryos.  Results are 
summarized in Figure 2-4. 
The first region is upstream from the translational start site and ranges from -743 
bp to -480 bp.  This region is hypomethylated at all CpG sites with the exception of a 
cluster of four CpG dinucleotides from -598 bp to -585 bp.  For all three sample types, a 
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similar pattern of methylation was observed in the sequence of these four CpG sites 
contained within a 14 bp segment of DNA, where sites -598, -589, and -585 are 
methylated with moderate to high frequency (38 to 100%), while site -593 is not 
methylated for any sequence read examined in any of the tissue types (Fig. 2-4).  
Interestingly, methylation of these sites seems to be maintained in a specific pattern 
across tissue types, where sites -598, -589, and -585 are methylated with 100% frequency 
in SCNT embryos, 63 to 70% frequency in donor cells, and only 38 to 50% frequency in 
IVF embryos.  Also within this region, CpG site -701 is appears more frequently 
methylated in SCNT embryos and donor cells compared to no methylation in IVF 
embryos.   
  A second region within SOX2 ranging from 600 bp to 1400 bp downstream from 
the transcriptional start site was methylated to varying degrees in donor cells, IVF 
embryos and SCNT embryos.  A second cluster of highly methylated sites exists within 
this region, and methylation for this sequence of CpG sites (562-669) is consistent for 
IVF and SCNT embryos and higher than that of donor cells for sites 652 and 669.  Few 
statistical differences were detected for CpG sites in the SOX2 gene due to the relatively 
low number of reads obtained. 
 
Methylation of KLF4 
Two large CpG islands are associated with the KLF4 gene ranging from 1800 bp 
upstream to 2200 bp downstream from the transcriptional start site in the third intron 
(Fig. 2-1).  In all sample types, methylation of the regions from -1218 to -361 and +1250 
to +1900 was quite low, averaging from 1 to 9% (Fig. 2-5).  The region upstream from 
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the transcriptional start site was not methylated at any CpG site in any of the tissue types 
examined (data not shown).  The region downstream of the transcriptional start site, from 
1553 to 1884, was methylated to a limited extent in donor cells, but only minimally 
methylated at a few loci in IVF or SCNT embryos.  The donor cell likewise has minimal 
methylation throughout the region (Fig. 2-5).  Interestingly, significant differences in 
frequency of methylation were observed for many CpG sites among the tissue types, even 
though the differences were not large in magnitude.  Most notable were differences in 
donor cells and IVF embryos from sites 1731 to 1806, as well as differences between 
SCNT embryos or donor cells compared to IVF embryos in the region from 1281 to 1495 
(Fig. 2-5). 
 
Discussion 
The aim of this project was to determine whether the DNA methylation patterns 
of POU5F1, NANOG, SOX2, KLF4, LIN28, and C-MYC were appropriately 
reprogrammed in SCNT embryos prior to implantation.  We accomplished this objective 
by measuring DNA methylation of the CpG islands associated with each gene in SCNT 
and IVF blastocysts.  We also measured the methylation status of the donor cell line to 
determine whether methylation patterns of SCNT embryos more closely resembled those 
of the donor cell line or IVF embryos.  The results of this study suggest that DNA 
methylation patterns of POU5F1, NANOG, and SOX2 in SCNT embryos are abnormally 
established at several CpG sites in pre-implantation SCNT embryos.  Across the broad 
CpG islands examined, levels of methylation of the NANOG and SOX2 genes were 
elevated and more closely matched the methylation patterns observed in donor cells.  On 
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the other hand, POU5F1 is relatively hypomethylated compared to donor cells and IVF 
embryos; this observation suggests that while reprogramming of POU5F1 occurs in 
SCNT embryos, the timing may be delayed compared to IVF embryos.  
Several studies have examined the methylation status of CpG sites proximal to the 
transcriptional start sites for POU5F1, NANOG, and SOX2 genes and observed abnormal 
methylation patterns in SCNT embryos (Yamazaki et al., 2006).  Aberrant epigenetic 
patterns likely contribute to cloning failure during preimplantation development and early 
gestation (Bourc'his et al., 2001; Dean et al., 2001; Kang et al., 2001; Ohgane et al., 
2001; Kang et al., 2002).  In this study, we examined previously uncharacterized CpG 
islands associated with the POU5F1, NANOG, and SOX2 genes, as well as three other 
genes not previously studied in bovine embryos, KLF4, LIN28, and C-MYC.  These later 
three genes were selected because they are likely to be involved in donor cell 
reprogramming (Takahashi et al., 2007; Yu et al., 2007).  CpG islands may or may not 
directly regulate expression, but can be methylated and are useful in determining the 
reprogramming status of an associated gene.   
DNA methylation is tightly regulated during embryonic development in order to 
enable proper gene expression and to reestablish appropriate epigenetic patterns during 
tissue differentiation.  Following fertilization, the maternal genome is passively 
demethylated throughout early embryonic stages (Monk et al., 1987; Howlett and Reik, 
1991; Rougier et al., 1998), while the paternal genome is actively demethylated 
immediately following fertilization (Mayer et al., 2000; Oswald et al., 2000).  SCNT 
embryos are susceptible to disruption of methylation patterns (Kikyo and Wolffe, 2000; 
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Kang et al., 2001; Bonk et al., 2008).  The demethylation that occurs in normal 
developing embryos is incomplete and abnormally timed in clones (Armstrong et al., 
2006).   
As expected, CpG sites associated with the POU5F1 gene are more frequently 
methylated in donor cells than in IVF embryos.  This difference suggests that 
reprogramming of the epigenome for POU5F1 is underway in IVF embryos, likely a 
consequence of ongoing cellular differentiation, yet the process is not quite complete.  
Alternatively, the overall lower level of methylation for CpG sites associated with 
POU5F1 in SCNT embryos suggests that the timing of reprogramming in clones may be 
delayed compared to IVF blastocysts.  Moreover, the disrupted methylation pattern may 
contribute to the abnormal expression of POU5F1 observed in clones (Boiani et al., 
2002; Bortvin et al., 2003; Aston et al., 2010).  Because POU5F1 is critical for early 
development (Nichols et al., 1998; Niwa et al., 2000), abnormal expression of this gene 
imposes an impediment to normal development.  Yamazaki et al. (2006) showed that 
reprogramming of POU5F1 occurs gradually throughout development, and our results 
confirm that reprogramming of methylation patterns does indeed occur.  The relatively 
low level of overall methylation for SCNT embryos may be the result of gradual 
demethylation of the POU5F1 gene during early embryo development.  Alternatively, the 
low abundance of methylated CpG sites in SCNT embryos may be a consequence of 
fewer trophectoderm cells present in cloned embryos (Koo et al., 2002).  Due to ongoing 
active cellular differentiation, one would expect higher levels of methylation for 
pluripotency factors in trophectoderm cells (Hattori et al., 2004).  A loss of 
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trophectoderm cells in cloned embryos, which are often smaller in size compared to IVF 
embryos, could conceivably influence the proportion of methylated CpG sites acquired 
from whole embryo samples.  Interestingly, one cluster of CpG sites within POU5F1 was 
identified for which methylation frequency was substantially higher in SCNT embryos 
compared to IVF.  However, the role of these specific CpG sites in regulating gene 
expression is, as yet, unclear nor is it known whether these loci are resistant to 
reprogramming or sensitive  to the reestablishment of methylation within the blastocyst 
stage.  Overall, the methylation patterns observed for POU5F1 are atypical of those 
observed in IVF and highlight the aberrant nature of the SCNT reprogramming among 
specific genes.    
NANOG is involved in the maintenance of pluripotency during embryo 
development, prevents differentiation (Chambers et al., 2003), and is essential to early 
development.  Aberrant NANOG methylation may hinder expression in the early embryo 
and perturb SCNT embryo development.  However, in this study, the overall patterns of 
methylation across donor cells, IVF and SCNT embryos were broadly similar and 
relatively moderately methylated (with a few exceptions for IVF embryos where no 
methylation was detected).  Interestingly, NANOG contains a CpG site at location 523 
characterized by a sudden increase in methylation, whereas neighboring sites were only 
moderately methylated.  That higher levels of methylation were consistently maintained 
for this site in all sample types suggest that CpG site 523 may be functionally important, 
yet additional experiments would be necessary to establish a specific role for this 
particular locus in regulating NANOG expression.     
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SOX2 maintains potency and directs cell lineage fate in combination with 
POU5F1 (Avilion et al., 2003).  SOX2 contains a CpG island upstream from the 
translational start site that is largely hypomethylated in donor cells, IVF and SCNT 
embryos.  An exception to this regional hypomethylation is a 14 bp sequence 
approximately 600 bp upstream from the translational start site that contains four CpG 
sites.  Three of these loci are moderately methylated in donor cells and IVF embryos and 
highly methylated in SCNT embryos, whereas the fourth site is void of methylation in all 
tissue types.  From this data set, it is not possible to know whether or not the elevated 
methylation at the three CpG sites in this region is a consequence of incomplete 
reprogramming or premature establishment of hypermethylation for this pluripotency 
gene in cloned embryos.  The apparent tight regulation of methylation within this small 
region of DNA, as well as the absence of methylation on surrounding CpG dinucleotides 
suggests that this sequence of CpG sites may play a key regulatory role for SOX2 
expression.  An analysis of this region of the SOX2 gene promoter using PROMO 
(Messeguer et al., 2002) revealed that eight transcription factors have affinity for this 
sequence: SP1, Mad, fα-fε, BTEB3, ADR1, GAGA Factor, P53, and Pax-6.  
Interestingly, Pax-6 is known to regulate SOX2 expression (Wen et al., 2008).  Future 
studies should focus on the impact of high methylation at these three CpG sites in the 
promoter for SOX2 on recruitment of critical transcription factors, such as Pax-6, and 
subsequent expression of the SOX2 gene. 
 Within the donor cell line, we observed a high degree of variation of methylation 
among individual cells.  There was an average of 125 reads among donor samples, which 
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generated a large enough data set to see the methylation pattern of several hundred cells 
gathered from a pool of potential donor cells.  This allowed us to look at the possible 
effect of random donor cell selection.  What we observe is that among the genes 
examined, a small percentage of donor cells lack methylation.  In the case of the 
upstream region of SOX2, 26% of donor cells contain no DNA methylation at any site.  
As methylation at these locations may carry over from the donor cells within SOX2, the 
lack on methylation on in 26% of donor cells suggests that some donor cells transferred 
during SCNT are unmethylated at these CpG sites and the clone would inherit an 
unmethylated pattern.  This may account for why some clones are better prepared for 
early development. 
Overall, we examined 336 CpG sites across six genes involved in reprogramming 
and early development SCNT and IVF embryos.  We found that SCNT embryos harbor 
some aberrations in patterns of DNA methylation, although these abnormalities were 
often localized to small regions or specific CpG sites.  The most profound evidence for 
inappropriate genome reprogramming was obtained for the POU5F1 gene, which was 
overall hypomethylated compared to IVF embryos.  Future work should aim to determine 
the mechanism(s) responsible for appropriate reprogramming of NANOG and SOX2, and 
to determine whether or not this mechanism is defective or inefficient for reprogramming 
the POU5F1 gene.  Furthermore, future work should establish the consequences of 
aberrant methylation following implantation and determine the regulatory nature of the 
three CpG sites identified within the promoter region of SOX2. 
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Table 2-1.  Primers Used for Bisulfite Sequencing 
Gene Primer        Location 
POU5F1  
Forward GTTAGAGGTTAAGGTTAGTGGG -110 
Reverse GTTTTATGATTTGTGTGGAGGGATG 218 
Forward TTTGGATGAGTTTTTAAGGGTTTT 99 
Reverse TTGGATAAGGAGAAGTTGGAG 389 
Forward TGGAGTYGAATTTTGAGGAGG 384 
Reverse TTTTAGGGTTAAGTGTGGTTT 827 
Forward TGGTGAAAGTTTTAGTGTAGTGTA 3961 
Reverse GTATTTAAATTGAGGTGTTTGT 4507 
NANOG   
Forward ATGTTTGAAGAAAGTTAYGTGTT 253 
Reverse AAGGTGTGTTAGAGATGGTAT 746 
SOX2  
Forward TAAGAGAGTGGAAGGAAATTTAG -1587 
Reverse GTTTTGTTTGGTTTGTATTTGTG -1277 
Forward TGGTTTGATTTTAGTTTTGGAGG -770 
Reverse AGTGGGATAGTTTTATTGAGTTAT -477 
Forward AGTGGGATAGTTTTATTGAGTTAT -471 
Reverse TTGTTAAGGTAGAGAAGAGAGT 20 
Forward GATGGTTTAAGAGAATTTTAAGATG 580 
Reverse TAGTATGATGTAGGATTAGTTGGG 943 
Forward TAGTATGATGTAGGATTAGTTGGG 919 
Reverse TTAAAGAAAAAGAGGGAAATGGAG 1424 
KLF4  
Forward GTGTTTTGTAAAGTGTTTTGAGAT -1614 
Reverse GGGATTAGAGTAGGATTTTTGG -1274 
Forward GAGTTTAAGAAGGATTATGYGAG -1347 
Reverse GGTAGTTTTTYGGTTTGAGAGAG -725 
Forward GGTAGTTTTTYGGTTTGAGAGAG -748 
Reverse GTTTTGGGGTTYGGGTATT -178 
Forward GGTTTGAATTGGATTTAGTGTATA 1250 
Reverse TAGAGGTTTATTTGGGTATTGGAT 1532 
Forward GTGTTTTAAGATTAAGTAGGAGGT 1455 
Reverse GAGTTTAAATTAAAGAGGGGAAGA 1912 
LIN28  
Forward TGGAGTTAGGAATTTTGGTGTTTTA 196 
Reverse  AGGGGAGATTTAGGGTTTTTATTGT 796 
C-MYC  
Forward TTTTGTTTTAGATGATTTAAGAATATAGGA -506 
Reverse TTATTATTGTTTGGAAGGGTAGGGT -85 
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Figure 2-1.  Map of CpG islands and regions examined for methylation.  Horizontal 
line shows the first 2000 bp of the gene as well as 2000 bp upstream from the 
translational start site.  White boxes show exons.  Vertical lines represent CpG sites and 
grey boxes represent CpG islands.  Arrows indicate primers of the regions examined for 
methylation analysis. 
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Figure 2-2.  Heat map depicting methylation profile of POU5F1 in donor cells and 
blastocyst stage SCNT and IVF embryos.  The reads column indicates the total number 
of reads associated with each amplicon.  The average percent methylation across all CpG 
sites examined is also shown.  Position number specifies the bp location of the CpG site 
in relation to the translational start site.  Each heat map cell indicates the percentage of 
CpG sites positive for methylation.  Red corresponds to high methylation and blue to low 
methylation.  The significant difference table below each heat map panel provides the 
results of Fisher’s exact tests for each CpG site for the indicated pair-wise comparison 
with Bonferroni correction for multiple testing (SAS).  A stared box indicates a 
statistically significance difference in methylation (P <0.05).   
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Figure 2-3.  Heat map depicting methylation profile of NANOG in donor cells and 
blastocyst stage SCNT and IVF embryos.  The reads column indicates the total number 
of reads associated with each amplicon.  The average percent methylation across all CpG 
sites examined is also shown.  Position number specifies the bp location of the CpG site 
in relation to the translational start site.  Each heat map cell indicates the percentage of 
CpG sites positive for methylation.  Red corresponds to high methylation and blue to low 
methylation.  The significant difference table below each heat map panel provides the 
results of Fisher’s exact tests for each CpG site for the indicated pair-wise comparison 
with Bonferroni correction for multiple testing (SAS).  A stared box indicates a 
statistically significance difference in methylation (P <0.05).   
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Figure 2-4.  Heat map depicting methylation profile of SOX2 in donor cells and 
blastocyst stage SCNT and IVF embryos.  The reads column indicates the total number 
of reads associated with each amplicon.  The average percent methylation across all CpG 
sites examined is also shown.  Position number specifies the bp location of the CpG site 
in relation to the translational start site.  Each heat map cell indicates the percentage of 
CpG sites positive for methylation.  Red corresponds to high methylation and blue to low 
methylation.  The significant difference table below each heat map panel provides the 
results of Fisher’s exact tests for each CpG site for the indicated pair-wise comparison 
with Bonferroni correction for multiple testing (SAS).  A stared box indicates a 
statistically significance difference in methylation (P <0.05).   
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Figure 2-5.  Heat map depicting methylation profile of KLF4 in donor cells and 
blastocyst stage SCNT and IVF embryos.  The reads column indicates the total number 
of reads associated with each amplicon.  The average percent methylation across all CpG 
sites examined is also shown.  Position number specifies the bp location of the CpG site 
in relation to the translational start site.  Each heat map cell indicates the percentage of 
CpG sites positive for methylation.  Red corresponds to high methylation and blue to low 
methylation.  The significant difference table below each heat map panel provides the 
results of Fisher’s exact tests for each CpG site for the indicated pair-wise comparison 
with Bonferroni correction for multiple testing (SAS).  A stared box indicates a 
statistically significance difference in methylation (P <0.05).   
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CHAPTER 3 
 
DNA METHYLATION OF THE LIN28 PSEUDOGENE FAMILY 
 
 
Abstract 
DNA methylation is a covalent attachment on DNA that directs epigenetic 
silencing of selected regions of DNA.  Methylation is widespread throughout the genome 
and contributes to various forms of genomic regulation.  Pseudogenes are decayed copies 
of duplicated genes that spread throughout the genome by retrotransposition.  
Pseudogenes are transcriptionally silenced by DNA methylation, but little is know about 
the mode of epigenetic regulation of pseudogenes.  Using bisulfite next generation 
sequencing we examined the methylation status of four pseudogenes of the LIN28 family 
along with the parent gene to determine the methylation status of dispersed pseudogenes 
sharing a common origin.  Our aim was to determine whether pseudogenes derived from 
LIN28 maintain the same pattern of methylation as the LIN28 parent gene or acquire a 
methylation pattern that reflects the region of insertion.  Results of this study indicate that 
pseudogenes are methylated in patterns specific to the local genomic environment and do 
not recapitulate the methylation signature of the parent gene.   
 
Introduction 
DNA methylation is utilized to control diverse aspects of genome regulation and 
transcriptional activity.  Methylation of mammalian DNA involves the addition of a 
methyl group to the 5’-carbon the cytosine in cytosine-guanine dinucleotides (termed 
CpG sites).  This system of methylation likely evolved from a genomic defense system 
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responsible for preventing the spread of parasitic genetic elements.  DNA methylation 
has since evolved to play an active role in maintaining genetic structure and genome 
regulation (Chen et al., 1998).  Methylation is involved in X-chromosome inactivation 
(Mohandas et al., 1981; Csankovszki et al., 2001), silencing of transposable elements 
(Liu et al., 1994; Woodcock et al., 1997; Yoder et al., 1997; Walsh et al., 1998), tissue-
specific gene expression (De Smet et al., 1996; De Smet et al., 1999; Jaenisch and Bird, 
2003; Shiota, 2004), and gene imprinting (Bartolomei et al., 1993; Li et al., 1993; Stoger 
et al., 1993; Bird, 2002).  DNA methylation is widespread throughout the genome, and 
the maintenance of methylation patterns is highly regulated and tissue-specific (Eckhardt 
et al., 2006; Illingworth et al., 2008).  Patterns of methylation are established and 
maintained by DNA methyltransferase (DNMT) enzymes (Holliday and Pugh, 1975; 
Riggs, 2002; Jones and Liang, 2009).  The absence of DNA methylation results in 
embryonic lethality, which highlights the crucial role of DNA methylation in 
development (Li et al., 1992; Okano et al., 1999; Goll and Bestor, 2005). 
 Methylation regulates pseudogenes within the genome (Grunau et al., 2000; 
Eckhardt et al., 2006).  Pseudogenes are decayed copies of active genes that have arisen 
from either a duplication event in which the entire gene, or portion of a gene, is 
duplicated (non-processed pseudogenes) or from the retrotransposition of a gene 
transcript back into the genome (processed pseudogenes).  An analysis of the human 
genome estimates that as many as 19,000 pseudogenes are evenly distributed throughout 
the genome, and approximately 70% of these are processed pseudogenes (Riggs, 2002; 
Rauch et al., 2009).  Pseudogenes primarily arise from parent genes that are 
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transcriptionally active within the germ line, and 10% of genes within the human genome 
have at least one corresponding pseudogene (Riggs, 2002; Laurent et al., 2010).   
The same regulatory network that inhibits transposable element movement likely 
induces DNA methylation on pseudogenes.   Methylation of pseudogenes is elevated in 
embryos, likely as a mechanism for preventing the spread of retrotransposible elements 
during embryogenesis (Eckhardt et al., 2006; Zhang et al., 2006).  In plants, the 
inactivation of methyltransferases resulted in the widespread activation of transposable 
elements and pseudogenes (Zhang et al., 2006), demonstrating that DNA methylation is 
sufficient to prevent the activation of pseudogenes.  In humans, pseudogenes are highly 
methylated, presumably to prevent transposition (Eckhardt et al., 2006). 
In order to better understand how methylation patterns are established and 
maintained on pseudogenes, we examined the methylation status of four pseudogenes 
derived from the translational enhancer LIN28.  This gene is involved in early 
development and acts as a switch for developmental timing (Moss et al., 1997).  LIN28 
can also act as a reprogramming factor in the production of induced pluripotent stem cells 
(Yu et al., 2007; Darr and Benvenisty, 2009).   
The protein-coding region of LIN28 contains a high concentration of CpG sites, 
making the gene a potential target for DNA methylation once inserted elsewhere in the 
genome as a pseudogene.  LIN28 has given rise to 10 processed pseudogenes within the 
bovine genome that vary in length between 100 to 4000 bp.  By measuring the 
methylation levels of selected pseudogenes and the gene of origin, we sought to 
determine whether the same regulatory mechanism that maintains methylation of the 
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LIN28 parent gene also controls the methylation status of LIN28 pseudogenes.  
Additionally we examined the expression of genes near the insertion site to determine 
whether pseudogene methylation is involved in transcriptional control of adjacent genes.   
 
Materials and Methods 
Fibroblast Cell Culture 
Bovine fibroblasts isolated from skin were cultured in DMEM F12 (Thermo 
Scientific HyClone Laboratories, Logan, UT) supplemented with 15% fetal bovine serum 
(FBS) (Thermo Scientific HyClone Laboratories), 100 U/ml penicillin, and 100 mg/ml 
streptomycin.  Cells were cultured at 37°C with 5% CO2.  For cell collection fibroblasts 
were treated with 0.25% trypsin prior to collection for RNA and DNA isolation. 
 
Oocyte Maturation 
Bovine ovaries were collected at a local abattoir (E.A. Miller, Hyrum, UT) and 
used for collecting oocytes.  Oocytes with 3 to 8 mm follicles were aspirated along with 
cumulus complexes.  Following aspiration, cumulus oocyte complexes were cultured at 
37°C with 5% CO2 for 18 to 22 hr in TCM 199 maturation medium containing 10% FBS 
(Thermo Scientific HyClone Laboratories), 0.05 mg/ml follicle stimulating hormone, 5 
mg/ml luteinizing hormone, 100 U/ml penicillin, and 100 mg/ml streptomycin.   
 
In Vitro Fertilization 
Following 18 to 22 hr of oocyte maturation, cryopreserved bovine semen 
(Hoffman AI, Logan, UT) was thawed in a 37°C water bath.  Live sperm were isolated by 
centrifugation through a 45%/90% percoll gradient.  Sperm were suspended in Tyrode’s 
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albumin lactate pyruvate (TALP) and used for oocyte fertilization.  Twenty-four hr post 
fertilization, cumulus cells were removed by vortexing the cumulus oocyte complex in 
phosphate buffered saline (PBS) containing 0.32 mM sodium pyruvate, 5.55 mM 
glucose, 3 mg/ml BSA, and 10 mg/ml hyaluronidase.  Oocytes were washed through six 
drops of PBS and placed in co-culture dishes plated with cultured cumulus cells and 
cultured in CR2 medium.   
 
Tissue Collection and RNA Isolation 
Twenty-five pooled blastocyst embryos were collected after 8 days of culture in 
CR2 medium, snap frozen with liquid nitrogen, and stored at -80°C.  Twenty-five pooled 
oocytes were collected after 22 hr of maturation, vortexed for 5 min in PBS to remove 
cumulus cells, snap frozen with liquid nitrogen, and stored at -80°C.  RNA was isolated 
from oocyte and blastocyst embryo samples using the RNeasy Mini Kit (Qiagen, 
Germantown, MD) following manufacturer’s instructions.  Bovine brain, liver, testes 
tissue samples were collected immediately after slaughter and suspended in RNALater 
(Ambion, Austin, TX).  Samples were stored overnight at 4°C.  Fibroblasts were 
collected as described above.  RNA was isolated from brain, liver, testes, and fibroblasts 
using TRIzol reagent (Life Technologies, Carlsbad, CA).  Tissue samples were 
homogenized in 3 ml TRIzol with a tissue homogenizer.  Cells were incubated for 5 min 
at room temperature, combined with 0.6 ml chloroform, and mixed by inversion.  
Samples were centrifuged at 12,000 × g for 15 min at 4°C, the upper aqueous phase was 
removed and combined with 1.5 ml isopropyl alcohol, then centrifuged at 12,000 × g for 
10 min at 4°C.  Supernatant was removed and the RNA was washed with 75% ethanol 
	   	  
	  
98 
98 
and centrifuged again, then dried and resuspended in H2O.  Isolated RNA was 
immediately converted to cDNA using the Superscript III Reverse Transcriptase Kit (Life 
Technologies) following manufacturer’s protocol.  Samples were stored at -20°C until 
use. 
 
DNA Isolation and Bisulfite Conversion 
Twenty-five pooled oocytes and blastocyst embryos were snap frozen with liquid 
nitrogen and stored at -80°C until direct bisulfite conversion.  DNA from brain, liver, 
testes, and fibroblast samples were collected from the interphase of the TRIzol treatment 
used for RNA collection.  The collected interphase was combined with 0.9 ml ethanol, 
mixed by inversion, and centrifuged at 2000 × g for 5 min at 4°C.  The pellet was 
suspended with 75% ethanol and washed by centrifugation three times.  The DNA pellet 
was resuspended in 0.1 µM sodium citrate.  The isolated DNA underwent bisulfite 
conversion using the EZ DNA Methylation Kit (Zymo Research, Irvine, CA) according 
to manufacturer’s recommendation.  DNA was stored at -20°C until use. 
 
Bisulfite PCR and 454 Sequencing 
Primers for bisulfite-converted DNA were designed for each pseudogene and the 
LIN28 parent gene.  Primers covered CpG sites within and immediately surrounding the 
protein-coding sequence of LIN28.  As the four examined pseudogenes maintain high 
sequence identity to the LIN28 parent gene and one another, primers were designed 
specific to each pseudogene to ensure only amplification of the target pseudogene.  
Bisulfite-converted DNA was used as a template for 25 µl PCR reactions using 1 to 3 µl 
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DNA.  Reactions were carried out using the Mastercycler thermal cycler (Eppendorf, 
New York, NY).  Primer concentrations were 0.6 µM for all reactions.  All reactions 
were carried out using the following cycling parameters: 30 cycles of 94°C for 1 min, 
annealing temperature ranging from 54 to 59°C for 1 min, and 72°C for 1 min for 30 
cycles.  A second PCR was preformed using primers including the original primer 
sequence with the addition of the 454 adapter sequence, key sequence, and molecular 
identification tags (designated as N) to differentiate individual tissue samples (adapter A 
CGTATCGCCTCCCTCGCGCCATCAGNNNNNNNNNN attached to the forward 
primer and adapter B CTATGCGCCTTGCCAGCCCGCTCAGNNNNNNNNNN 
attached to the reverse primer).  The following cycling parameters were used: 94°C for 
30 sec, annealing temperature ranging from 55 to 60°C for 30 sec, and 72°C for 30 sec 
for 15 cycles.  The second reaction used 1 µl of PCR product from the first PCR and 0.3 
µM primer.  All PCR samples used GoTaq Green Master Mix (Promega, Madison, WI).  
All PCR reactions were carried out on a Mastercycler thermal cycler (Eppendorf).  PCR 
reactions were purified with AMPure beads (Beckman Coulture, Brea, CA) and 
quantified using PicoGreen (Life Technologies).  PCR product was sequenced using the 
454 GD FLX Titanium DNA sequencer (Roche, Indianapolis, IN).  Amplicon libraries 
were subjected to emulsion PCR to generate DNA-coated beads, loaded onto a 
PicoTiterPlate, and sequenced with a FLX Titanium DNA sequencing Kit according to 
the manufacturer’s protocol. 
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End-Point RT-PCR 
End-point RT-PCR reactions targeting bovine cDNA were carried out using the 
Mastercycler thermal cycler (Eppendorf).  GoTaq Green Master Mix (Promega) was used 
on all reactions with primer concentrations of 0.6 µM using the following cycling 
parameters: 40 cycles of 94°C 15 sec, annealing temperature ranging from 58 to 60°C for 
15 sec, and 72°C for 30 sec for 35 cycles.  Following cycling, samples were 
electrophoresed on a 1% agarose gel and imaged.   
 
Sequence Analysis 
Sequencing data was analyzed to generate the frequency of methylation using 
BISMA analysis software (Rohde et al., 2010).  Data are expressed as the percentage of 
methylated CpG sites by normalizing methylation frequency data to the number of 
sequence reads obtained. 
 
Results 
We assessed the methylation status of four LIN28 processed pseudogenes in six 
bovine tissue samples, including brain, liver, testes, fibroblast cells, IVF blastocyst stage 
embryo, and oocyte.  Three of the LIN28 pseudogenes contain the entire protein-coding 
sequence as well as transcribed regions up and downstream from the protein-coding 
region.  These three pseudogenes are likely the products of retrotransposition of the 
LIN28 transcript following intron excision (Fig. 3-1).  A fourth pseudogene contains only 
the terminal portion of the protein-coding region and downstream transcript (Fig. 3-1).  
These four pseudogenes were selected for examination based on their retention of the 
	   	  
	  
101 
101 
protein-coding region, as well as insertion location and number of CpG sites.  The 
pseudogenes examined were as follows: LIN28P-Ch:3 (LOC784466) inserted into 
chromosome 3 approximately 20Kbp upstream of the UBQLN4 gene (84% identity with 
LIN28), LIN28P-Ch:7 (LOC781442) on chromosome 7 inserted into the fourth intron of 
the MAN2A1 gene (97% identity with LIN28) and LIN28P-Ch:26 (LOC539705) on 
chromosome 26 inserted in the first intron of ACADSB (97% identity with LIN28) (Fig. 
3-2).  In addition, an identical pair of processed pseudogenes LIN28P-Ch28 (LOC785096 
and LOC785075) on chromosome 28 was included; these pseudogenes have no proximity 
to any gene (90% identity with the LIN28 gene) (Fig. 3-2).  The LIN28P-Ch:28 
pseudogenes likely arose from the insertion of a single pseudogene into chromosome 28, 
followed by a duplication event that generated a second copy of the initial pseudogene.  
The two pseudogenes are nearly 100% identical to one another, and differ by only three 
nucleotides and cannot be distinguished from one another.  Primer amplification was 
indiscriminate of either pseudogene and analysis was carried out as though it were a 
single targeted site. 
Primer sets were designed to profile each individual pseudogene for a sequence 
within the protein-coding region.  Due to the high sequence identity between the 
pseudogenes and parent gene, the overlap of examined CpG sites was limited by our 
ability to amplify each individual pseudogene.  Pseudogenes LIN28P-Ch:3, LIN28P-Ch:7 
and LIN28P-Ch:26 all contain considerable overlap between identical CpG sites.  
LIN28P-Ch:26 contains overlap of only two CpG sites with the LIN28 parent gene.  The 
LIN28 parent gene also shares only three overlapping CpG sites with LIN28P-Ch:28 (Fig. 
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3-3).  Because of the restricted overlap of CpG specific sites, our assessment regarding 
differences between individual CpG dinucleotides was limited.  Rather we focused our 
analysis to consider patterns of methylation among the amplified regions as a whole. 
 
Methylation Status of the LIN28 Family 
Our results indicate that LIN28 and all examined pseudogenes were methylated in 
all bovine cell and tissue types examined.  Seven CpG dinucleotides within the LIN28 
parent gene were analyzed.  These dinucleotides are located in the third exon of LIN28.  
All of the CpG sites were methylated in each tissue to varying degrees (Fig. 3-3).  In 
addition, all pseudogenes examined were methylated in all tissue samples.  However, 
each pseudogene demonstrated a distinct methylation pattern that differs sharply from the 
LIN28 gene, and that correlates to the pseudogene insertion location.   
The pseudogenes LIN28P-Ch:3 and LIN28P-Ch:28 were inserted into a location 
not associated with any gene, and both of these pseudogenes share a similar overall 
pattern of methylation (Fig. 3-3).  We analyzed methylation at nine CpG dinucleotides 
within LIN28P-Ch:3 and eight CpG dinucleotides in LIN28P-Ch:28.  In both 
pseudogenes, oocytes had the lowest levels of overall methylation in these pseudogenes 
with 52% average methylation across all CpG sites for LIN28P-Ch:3 and 41% for 
LIN28P-Ch:28.  In contrast, average methylation was highest in blastocysts, at 81% for 
LIN28P-Ch:3 and 92% for LIN28P-Ch:28.  The methylation patterns of both 
pseudogenes apparently deviated from patterns observed in the LIN28 parent gene.  
Within the LIN28 parent gene, oocytes had the highest frequency of methylation with an 
average of 93% across all CpG sites examined.  Alternatively, the methylation of the 
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parent gene was lowest in blastocyst embryos, with only 56% of CpG sites carrying the 
methyl mark (Fig. 3-3).  In LIN28P-Ch:28 we observed three overlapping CpG 
dinucleotides with the LIN28 parent gene.  Although limited, within these three 
overlapping sites, the inverse pattern of methylation between the LIN28 parent gene and 
pseudogenes LIN28P-Ch:3 and LIN28P-Ch:28 is maintained.   
In contrast to the tissue-specific methylation patterns, pseudogenes LIN28P-Ch:7 
and LIN28P-Ch:26 both have a hypermethylated pattern.  Both LIN28P-Ch:7 and 
LIN28P-Ch:26 were inserted into gene bodies.  LIN28P-Ch:7 is inserted into the fourth 
intron of the gene MAN2A1.  Over 90% of the 28 CpG sites inspected within this 
pseudogene were methylated in all tissue samples.  The LIN28P-Ch:26 pseudogene lies 
within the first intron of the gene ACADSB and is 20 kbp from the gene IKZF5.  As for 
LIN28P-Ch:7, all 28 CpG sites examined for the LIN28P-Ch:26 pseudogene were highly 
methylated at greater than 90% frequency (Fig. 3-3).  The hypermethylation observed in 
both of these pseudogenes is in sharp contrast to the moderate levels of methylation of 
the LIN28 parent gene and pseudogenes not inserted into gene bodies, none of which 
were as consistently hypermethylated for all tissue samples.   
These apparent differences in methylation correlate to the location of insertion of 
the pseudogene.  LIN28 pseudogenes inserted into gene bodies were hypermethylated.  
Alternatively, LIN28 pseudogenes with an insertion location distant from a gene varied in 
the pattern of methylation in a tissue-specific manner, although these tissue-specific 
patterns were inverse with respect to the LIN28 parent gene (Fig. 3-3). 
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Single CpG Demethylation  
Both LIN28P-Ch:7 and LIN28P-Ch:26 contain a single CpG dinucleotide that is 
characterized by a low frequency of methylation in a tissue-specific manner.  The 
LIN28P-Ch:7 CpG dinucleotide at site 23 (Fig. 3-3) is under-methylated in three tissues.  
Methylation of this site is only 45% in the testes and blastocyst, whereas this site is 
devoid of any methylation in fibroblast cells.  The same CpG dinucleotide 23 was 
additionally measured within the LIN28P-Ch:3 sequence, yet this site retained a high 
level of methylation for all tissues examined (Fig. 3-3). 
 LIN28P-Ch26 contains a similar CpG dinucleotide that is undermethylated in a 
tissue-specific manner at CpG site 16 in IVF blastocyst and oocyte samples.  Both 
samples are hypomethylated with a 13% methylation frequency in IVF blastocyst and 5% 
frequency in oocytes, yet highly methylated for other tissue types (Fig. 3-3).  
 
Expression of Genes Adjacent to LIN28 Pseudogenes  
End-point RT-PCR was performed to examine expression of LIN28 and genes 
closely adjacent to the four LIN28 pseudogenes examined to determine whether 
methylation of pseudogenes correlated with differences in gene expression.  Expression 
of the genes DHDDS, MAN2A1, ACADSB, and IKZF5 were measured in testes, liver, 
brain, fibroblast, IVF blastocyst, and oocyte samples (Fig. 3-4).  DHDDS, MAN2A1, and 
ACADSB expression did not correspond to methylation patterns of adjacent pseudogenes 
(Figs. 3-3 and 3-4).  IKZF5 is proximal to LIN28P-Ch:26, which does contain a tissue-
specific methylation pattern of a single CpG site.  Interestingly, the expression pattern for 
IKZF5 mirrors the pattern of methylation in that this gene is not expressed in oocytes or 
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blastocyst embryos (corresponding to samples with low methylation at site 16), but 
highly expressed in other tissue types (corresponding to samples with high methylation at 
site 16) (Figs. 3-3 and 3-4). 
 
Discussion 
The objective of our study was to determine whether the methylation of 
pseudogenes followed the same patterns as the functional parent gene by examining 
LIN28 as a case study.  An observation that the LIN28 pseudogenes maintained an 
identical or highly similar methylation pattern as the LIN28 parent gene would suggest 
that regulation of LIN28 methylation was specific to the sequence of the gene and that 
methylation of pseudogenes with high sequence identity was maintained by the same 
mechanism(s) that maintained methylation of the LIN28 parent gene.  Alternatively, an 
observation that pseudogene methylation patterns deviated from the parent gene would 
indicate that pseudogenes are subject to local regulation of methylation patterns.  In this 
study, we observed that LIN28 pseudogenes do not recapitulate the same methylation 
status as LIN28, but rather appear to acquire methylation patterns independent of the 
parent gene.  Furthermore, we observed that methylation levels of the examined 
pseudogenes correlate to the location of insertion.  LIN28 pseudogenes inserted into gene 
bodies were hypermethylated in all tissues examined.  In contrast, pseudogenes inserted 
into genomic regions that are not proximal to genes had reduced overall methylation and 
the methylation pattern was dependent upon the tissue type.  Additionally, pseudogenes 
not associated with genes had less methylation in tissue samples that were highly 
methylated in the parent gene.  
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We measured methylation of seven CpG dinucleotides located within the third 
exon of the LIN28 gene.  Methylation of CpG dinucleotides within the gene body is 
generally associated with transcriptionally active genes (Rauch et al., 2009; Laurent et al., 
2010).  This pattern is in contrast to methylation of the 5’ upstream and promoter regions 
of genes, which are typically associated with transcriptional silencing.  Methylation of 
these seven CpG dinucleotides was dependent upon tissue type.  Notably, oocytes had the 
highest levels of methylation within the LIN28 parent gene.  Oocytes generally maintain 
low levels of global methylation relative to somatic cells (Razin et al., 1984; Monk et al., 
1987).  Following fertilization, global methylation levels decline further and are then 
reestablished during embryonic and somatic cell development (Mayer et al., 2000; 
Oswald et al., 2000; Hajkova et al., 2002; Morgan et al., 2005).  The methylation level 
observed in the LIN28 parent gene is counter to this pattern.  However, methylation levels 
measured in the LIN28P-Ch:3 and LIN28P-Ch:28 pseudogenes are consistent with 
changes in methylation levels on a global level.  Within both these pseudogenes, oocytes 
maintained low levels of methylation, and somatic cells maintained high levels of 
methylation.  It is possible that the methylation patterns observed for LIN28P-Ch:3 and 
LIN28P-Ch:28 are maintained by the same mechanism that maintains global levels of 
methylation, while methylation of the LIN28 parent gene is maintained by a separate 
mechanism.   
We also observed that methylation of pseudogenes depends on the genomic 
context into which the pseudogene was inserted.  Both pseudogenes inserted into a gene, 
LIN28P-Ch:7 and LIN28P-Ch:26, are hypermethylated in all tissues.  On the other hand, 
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both pseudogenes not associated with a gene, LIN28P-Ch:3 and LIN28P-Ch:28, vary in 
the pattern of methylation within different tissue samples, but tissue methylation levels 
were similar between the two pseudogenes.  The similarity of methylation levels among 
all tissue types between similar pseudogenes suggests that pseudogenes share a common 
regulatory mechanism that establishes and maintains the methylation signature. 
Within both pseudogenes inserted into gene bodies, we observed single CpG 
dinucleotides that exhibit demethylation in a tissue specific manner.  Pseudogene 
LIN28P-Ch:7 was inserted into the fourth intron of MAN2A1.  Within the investigated 
CpG dinucleotides, a single CpG site at position 23 demonstrated a sharp reduction in 
methylation in the testes and blastocysts (both of which have 45% methylation), as well 
as fibroblasts (0% methylation).  The same CpG site measured in LIN28P-Ch:3 had no 
such reduction in methylation observed in any tissue studied, so it is likely that the 
apparent decline in methylation was specific to this pseudogene.  This hypomethylated 
site exists within the context of three closely aligned CpG dinucleotides, both of which 
are highly methylated in all tissues.  This site- and tissue-specific decrease in methylation 
points to a possible deliberate regulation of methylation at this locus that is unexplained 
in our study.   
The LIN28P-Ch:26 pseudogene is located within the first intron of ACADSB and 
20 Kbp upstream from IKZF5.  Within the LIN28P-Ch:26 pseudogene, a single CpG 
dinucleotide at site 16 is hypomethylated in the oocyte and blastocyst samples, a sharp 
contrast to the hypermethylated status of all surrounding CpG dinucleotides as well as the 
same CpG site in the four remaining tissues.  IKZF5 was not expressed in either oocytes 
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or blastocyst embryos.  Although the expression pattern of IKZF5 was correlated with the 
tissue-specific methylation patterns observed for the pseudogene, it is doubtful that this 
single CpG site is involved in the transcriptional regulation of IKZF5.  Although 
demethylation has been associated with transcriptional silencing (Hark et al., 2000; Lim 
and van Oudenaarden, 2007), the involvement of this specific CpG site in regulation of 
IKZF5 is unlikely, as the site is removed from the transcriptional start site by 20kbp.  
In conclusion, the four LIN28 pseudogenes examined in this study maintained 
methylation patterns that differed from the parent gene and from one another according to 
their location of insertion.  New knowledge on the regulation of pseudogenes via DNA 
methylation could contribute to greater understanding of the maintenance of global 
and/or regional patterns of methylation.  Future work on this topic should focus on 
defining methylation patterns for other pseudogene families to determine whether all 
pseudogenes are maintained in a similar manner or whether sequence specific patterns 
can be identified through analysis of pseudogenes.  Additionally, future studies should 
investigate expression of pseudogenes to determine how patterns of methylation correlate 
with transcript levels. 
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Table 3-1.  Primers Used for Bisulfite Sequencing and End-Point RT-PCR 
Bisulfite Primers 
 LIN28P-Ch:7 Forward GAAAAGTTTATGAAAGAGGTTAGGGTT 
  Reverse AAAACCCTCCATATACAACTTACTC 
 LIN28P-Ch:28  Forward TTTTAAGAAGTTTATTAAGGGTTTGGAA  
  Reverse TAACCCCCACCCACTATAACTTAAT 
 LIN28P-Ch:3  Forward TGTATATAATGGGGAGTAGGGGTT 
  Reverse CAAAAACCCTCCAAATACAACTTAC 
 LIN28P-Ch:26  Forward AAAGATAGTGGTGATATTGTGT 
  Reverse CCCAAAAACCAATAACTCTAA 
 LIN28  Forward TTTTTTTAGAGTAAGTTGTATATGGAGGG  
  Reverse TTACCAAAAACCACAAACTTCACTT  
 
End-Point RT-PCR Primers 
 MAN2A1 Forward GACCCATTTGGACATTCACC 
  Reverse TTTAGGATCAGGCCCACAAG 
 ACADSB  Forward TGGAAAACTCCTCCTCATGC 
  Reverse CAACTTGTTCCTGGGCAAAT 
 IKZF5  Forward GAGAAGAAACCGGAGCCTTT 
  Reverse AGGTCCTTTCAAACCCGTCT 
 DHDDS  Forward GTCATTTTGGGAGCGGTTCT 
  Reverse GCCAGTTTGTTGAAGCCTTG 
 LIN28  Forward TGCAGAAACGCAGATCAAAG 
  Reverse TTCTTCCTCCTCCCGAAAGT 
 ACTB Forward ATGGGCCAGAAGGACTCGTA 
  Reverse CTTCTCCATGTCGTCCCAGT 
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Figure 3-1.  The ten processed pseudogenes of LIN28 aligned to the LIN28 processed 
transcript.  The horizontal filled in lines represent each pseudogene with the location 
relative to the start of the LIN28 protein-coding region indicated at the bottom and 
measured in base pairs.  Vertical lines represents start and stop codons.  Sequence 
identity of each pseudogene to the LIN28 parent transcript is indicated on the right 
column and the chromosome of insertion is indicated on the left.  The dashed box shows 
the pseudogenes examined for methylation analysis 
 
 
 
  
!150% 350% 850% 1350% 1850% 2350% 2850% 3350% 3850%
LIN28&
LIN28P(Ch:26&
LIN28P(Ch:7&
LIN28P(Ch:28&
LIN28P(Ch:28&
LIN28P(Ch:3&
LOC100295351%
N/A%
N/A%
N/A%
N/A%
Start%%
Codon%
Stop%
Codon%Chromosome%
2%
26%
7%
28%
28%
3%
2%
7%
3%
29%
3%
Iden?ty%
100%
97%
97%
90%
90%
84%
85%
99%
96%
86%
84%
	   	  
	  
114 
114 
 
 
Figure 3-2.  LIN28 pseudogene locations on each chromosome.  Genes are represented 
by boxes with horizontal lines indicating approximate exon start locations.  Pseudogene 
location is indicated by the darkened box.  Arrows indicate gene transcription direction. 
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Figure 3-3.  Heat map of LIN28 and LIN28 pseudogene methylation profile.  
(following page)  LIN28 and pseudogenes include the examined tissues: testes, liver, 
brain, fibroblast, IVF blastocyst embryos, and oocytes.  The total number of sequencing 
reads is indicated next to each sample.  The average percentage methylation of CpG sites 
within the entire amplicon is shown for each pseudogene.  Each heat map cell indicates 
the percentage of CpG sites positive for methylation.  Red indicates high methylation and 
blue low methylation.  Each CpG site corresponds to a number indicated above each 
sample that indicates the placement of each CpG site in relation to the protein-coding 
region.  CpG sites of pseudogenes that do not correspond to a CpG location within the 
LIN28 parent gene are represented by ‘n’.   
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Figure 3-4.  End-point RT-PCR.  Expression of genes LIN28, ACADSB, MAN2A1, 
DHDDS, IKZF5 and ACTB in the testes, liver, brain, fibroblast, IVF blastocyst embryos 
and oocytes.  
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CHAPTER 4 
 
ACTIVATION OF THE P53 PATHWAY FOLLOWING BOVINE  
 
SOMATIC CELL NUCLEAR TRANSFER 
 
 
Abstract 
Embryos produced via somatic cell nuclear transfer have impaired development, 
reduced implantation rates, and have reduced viability as neonates.  Failure of cloned 
organisms to thrive is largely believed to be the product of failed somatic cell 
reprogramming.  Evidence points to a role for the P53 pathway in modulating 
reprogramming of the genome to a pluripotent state.  The tumor suppressor P53 
maintains genome integrity by activating apoptosis and inducing cell cycle arrest in 
response to cell stress or oncogene expression.  Activation of the P53 pathway is contrary 
to the needs of a pre-implantation embryo, which should express numerous genes 
responsible for cell growth and proliferation.  The aim of this study was to determine the 
extent of apoptosis in cloned bovine embryos throughout early development.  Our results 
indicate that the P53 pathway is activated in cloned embryos.  Additionally we observed 
that the cell cycle arrest activator P21WAF1/Cip1 (CDKN1A) was commonly expressed in 
cloned embryos, suggesting that P53 also induces cell cycle arrest in SCNT embryos.  
Activation of the P53 pathway may be the result of upregulation of the reprogramming 
factors C-MYC, SOX2, LIN28, and KLF4, as all of these genes are upregulated in cloned 
embryos.  These observations suggest that SCNT embryos are susceptible to blastomere 
depletion via apoptosis and cell cycle arrest in response to expression of reprogramming 
factors.  
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Introduction 
Somatic cell nuclear transfer (SCNT) is an established method for the production 
of transgenic animals and reproduction of domestic species with phenotypically valuable 
traits.  The procedure utilizes an enucleated oocyte as a recipient for a donor nucleus.  
Cloning has been successfully performed in a number of species.  Nevertheless, the 
benefits of cloning are hindered due to the limited success SCNT development (Wells et 
al., 1999).  Reconstructed SCNT embryos suffer from high rates of embryo failure and 
increased rates of fetal and neonate death.  The success rate of reconstructed oocytes 
resulting in live births is less than 3% (Thibault, 2003), and the low success limits the 
widespread use of the technique.  The low success rate is thought to be primarily the 
result of incomplete reprogramming of the donor cell genome (Wilmut et al., 1998; 
Colman, 1999; Kikyo and Wolffe, 2000; Solter, 2000; Dean et al., 2001; Humpherys et 
al., 2001; Reik et al., 2001; Niemann et al., 2008).  However, studies also point to high 
numbers of apoptotic cells in embryos as another factor that contributes to 
preimplantation and early gestational failure (Fahrudin et al., 2002; Hao et al., 2003; Jang 
et al., 2004; Gjorret et al., 2005; Im et al., 2006; Kumar et al., 2007). 
Programmed cell death by apoptosis is characterized by the morphological 
features of membrane blebbing, cell shrinkage, nuclear condensation, and DNA 
fragmentation (Kerr et al., 1972).  Apoptosis plays an active role during early embryonic 
development (Jurisicova et al., 1998; Hardy et al., 2001; Liu et al., 2002; Neuber et al., 
2002; Gjorret et al., 2003; Jurisicova et al., 2003).  Within preimplantation embryos, 
apoptosis is responsible for the removal of blastomeres damaged by exogenous stress, 
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carrying genetic abnormalities or that have reduced developmental potential (Fabian et 
al., 2005).   
Apoptosis in preimplantation embryos has been detected in multiple species and 
has been observed at higher frequency in embryos produced by SCNT than those 
produced by in vitro fertilization (IVF) (Fahrudin et al., 2002; Hao et al., 2003; Jang et 
al., 2004; Gjorret et al., 2005; Im et al., 2006; Kumar et al., 2007).  Cloned blastocysts 
have lower overall cell numbers than IVF embryos, an observation consistent with 
elevated levels of apoptosis in SCNT embryos (Koo et al., 2000; Fahrudin et al., 2002; 
Gjorret et al., 2005; Terashita et al., 2011).  The frequency of apoptotic cells and the cell 
count within preimplantation embryos are important indicators of developmental 
potential (Brison and Schultz, 1997; Brison and Schultz, 1998; Koo et al., 2000; Knijn et 
al., 2003).  Embryos exposed to factors that increase apoptosis have reduced implantation 
rates and decreased fetal birth weight (Wuu et al., 1999).  These observations suggest that 
increased apoptosis in early developing embryos can negatively affect post-implantation 
development. 
Apoptosis is regulated by P53, which is activated by cell stress, DNA damage, 
and oncogene expression.  Upon activation, P53 can induce pathways leading to 
senescence, cell cycle arrest, or apoptosis (Vousden and Lu, 2002).  Upon activation, P53 
translocates to the nucleus where it then induces expression of numerous genes that can 
either inhibit cell cycle progression or initiate programmed cell death.  In the event of cell 
cycle arrest, P21WAF1/Cip1 (CDKN1A) is transcriptionally upregulated by P53 (Brugarolas 
et al., 1999).  P21 is an inhibitor of cyclin-dependent kinases (CDKs) that are required for 
121 	  
	  
cell cycle progression.  Alternatively, P53 can initiate programmed cell death by 
upregulating the expression of genes that initiate apoptosis.  BAX is one such pro-
apoptotic gene (Oltvai et al., 1993; Miyashita and Reed, 1995).  BAX oligomerizes to 
form a channel on the mitochondrial membrane that induces the release of cytochrome c 
(Wei et al., 2001).  In healthy cells, BAX is inhibited by BCL2, which forms a 
heterodimer with BAX (Yin et al., 1994).  Under normal conditions, levels of BCL2 
exceed BAX levels.  This favors BCL2:BAX heterodimer formation and prevents 
activation of apoptosis.  However upon upregulation of BAX by P53, BAX oligomers 
become common, allowing for activation of the intrinsic apoptotic pathway via release of 
cytochrome c from the mitochondria (Basu and Haldar, 1998).   
Recently, the P53 pathway has been shown to modulate somatic cell 
reprogramming.  Reprogramming is known to activate P53-mediated apoptosis and cell 
cycle arrest (Qin et al., 2007; Mali et al., 2008; Zhao et al., 2008).  Knockout of P53 
dramatically improves the efficiency of generating induced pluripotent stem cells (iPSCs) 
(Zhao et al., 2008).  P53 null cell lines manifest dramatically higher reprogramming 
success rates (Hong et al., 2009; Kawamura et al., 2009).  Several genes upregulated by 
P53 prevent survival of reprogrammed cells (Hong et al., 2009).  Among these is 
P21WAF1/Cip1, an observation that suggests cell cycle arrest is an additional consequence of 
somatic cell reprogramming.  Cell lines that are recalcitrant to reprogramming can be 
successfully reprogrammed following P53 inhibition, providing further evidence for a 
role of P53 in somatic genome reprogramming (Utikal et al., 2009).   
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The observations that P53 plays a role in modulating reprogramming somatic 
DNA to a pluripotent state for the generation of iPSCs has relevance for SCNT and the 
high rate of failure for SCNT embryos.  The donor cell genome must undergo somatic 
cell reprogramming as a part of embryonic development.  However, reprogramming the 
somatic genome may activate P53 and trigger either cell cycle arrest or apoptosis.  P53 
accumulation within IVF embryos has been observed to act as a direct impediment to 
embryo viability and implantation (Ganeshan et al., 2010).  Decreased P53 expression led 
to significantly higher rates of fetal development following transfer of IVF embryos (Li 
et al., 2007).  Furthermore, the number of apoptotic cells within an embryo was 
negatively correlated with the quality and overall viability of the embryo (Hao et al., 
2004).  Apoptosis has been observed to be higher in cloned embryos as measured by 
DNA degradation and morphological changes associated with apoptotic cells (Fahrudin et 
al., 2002; Hao et al., 2003; Jang et al., 2004; Gjorret et al., 2005; Im et al., 2006; Kumar 
et al., 2007).  However, previous work associating SCNT with apoptosis have not 
measured the transcriptional activity of genes associated with the P53 pathway nor 
determined the cause of increased apoptosis following SCNT. 
The aims of this study were to determine the extent of P53-mediated apoptosis 
within SCNT embryos and to ascertain the factors that activate apoptosis following 
SCNT.  P53 expression can alter the developmental trajectory of SCNT preimplantation 
embryos and may function to remove inappropriately programmed or otherwise abnormal 
blastomeres from contributing to SCNT embryo development.  Our findings indicate that 
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P53-mediated apoptosis is activated within SCNT embryos and that activation is likely in 
response to aberrant expression of reprogramming factors.  
 
Materials and Methods 
Oocyte Maturation and In Vitro Fertilization 
Bovine ovaries were collected from a local abattoir (E.A. Miller, Hyrum, UT).  
Cumulus-oocyte complexes were isolated from 3 to 8 mm follicles by aspiration using an 
18-gauge needle.  TCM 199 maturation medium (Thermo Scientific HyClone 
Laboratories, Logan, UT) containing 10% FBS, 0.05 mg/ml follicle stimulating hormone, 
5 mg/ml leutinizing hormone, 100 U/ml penicillin, and 100 mg/ml streptomycin was used 
to culture aspirated cumulus-oocyte complexes for 18 to 22 hr.  Following oocyte 
maturation, cryopreserved bovine semen (Hoffman AI, Logan, UT) was thawed in a 
water bath, and live sperm were segregated through centrifugation in a 45%/90% percoll 
gradient.  Collected live sperm were resuspended in Tyrode’s albumin lactate pyruvate 
(TALP) and used to fertilize matured oocytes.  Twenty-four hr post-fertilization cumulus 
cells were removed from oocytes by vortexing in phosphate buffered saline (PBS) with 
0.32 mM sodium pyruvate, 5.55 mM glucose, 3 mg/ml BSA, and 10 mg/ml 
hyaluronidase.  Following vortexing, oocytes were washed in PBS and cultured in CR2 
medium atop a layer of cumulus cells. 
 
Donor Cell Culture and SCNT Production 
Bovine fibroblasts collected from skin samples were cultured in DMEM F12 
(Thermo Scientific HyClone Laboratories).  Culture medium was supplemented with 
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15% fetal bovine serum (Thermo Scientific HyClone Laboratories), 100 U/ml penicillin, 
and 100 mg/ml streptomycin.  Cells were seeded in a T25 culture flask and cultured at 
37ºC with 5% CO2.  Donor cells were collected prior to SCNT by treatment with 0.25% 
trypsin and resuspended in HEPES-buffered synthetic oviduct fluid.  Oocytes had 
cumulus cells removed following maturation as described above.  Oocytes in metaphase 
II were chosen for SCNT.  Oocytes were enucleated and a single donor cell was 
transferred to the perivitelline space.  Oocyte-donor cell fusion occurred in mannitol 
fusion medium (Wells et al., 1999) with two electric DC pulses of 2.2 kV/cm for 25 µsec.  
Following fusion, embryos were cultured in CR2 medium for 1 to 3 hr prior to activation, 
which was performed 23 to 25 hr post-maturation.  SCNT embryos were activated with 5 
min incubation in 5 mM ionomycin, followed by 4 hr incubation in 10 mg/ml 
cyclohexamide.  SCNT embryos were placed in CR2 medium atop a layer of cumulus 
cells. 
 
Fluorescence Immunohistochemistry 
IVF and SCNT embryos were collected at the 8-cell and expanded blastocyst 
stages.  Embryos were collected on three separate IVF/SCNT days.  Embryos were 
incubated overnight at 4ºC in fixative consisting of PBS with 4% formaldehyde and fixed 
overnight.  Embryos were then washed at room temperature in PBS with 0.05% Tween 
20 (Sigma-Aldrich, St. Louis, MO) (PBST) for 30 min, permeabilized at room 
temperature in PBS with 1% Triton X-100 for 30 min, and incubated overnight at 4ºC in 
blocking buffer consisting of PBST with 1% BSA.  Primary antibodies used were anti-
CDK2 (ab79379), anti-P53 (ab80645) (Abcam, San Francisco, CA), anti- P21WAF1/Cip1 
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(LS-C88148), and anti-BAX (LS-C63137) (Lifespan Biosciences, Seattle, WA).  
Embryos were incubated with the primary antibody at 37ºC for 3 hr, and then washed in 
PBST at room temperature for 30 min.  Secondary antibodies used were: Alexa Fluor 594 
IgG donkey anti-rabbit and Alexa Fluor 488 IgG donkey anti mouse (Life Technologies, 
Carlsbad, CA).  Embryos were incubated with the appropriate secondary antibody at 
37ºC for 2 hr, and then washed in PBST at room temperature for 30 min.  During each 
immunofluorescence analysis, two stage-appropriate IVF embryos were used as a 
negative control and incubated in the absence of the primary antibody, and underwent 
secondary antibody incubation.  Following primary and secondary antibody incubation, 
embryos were incubated with Hoechst 33342 at room temperature for 20 min and then 
washed in PBST at room temperature for 10 min.  Embryos were mounted onto slides in 
PBS with 70% glycerol and covered with a cover slip.  Slides were imaged with a Zeiss 
Axioobserver equipped with an Axiocam MRm camera 
 
TUNEL Assay 
Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay 
was carried out using the Click-iT TUNEL Alexa Fluor Imaging Assay (Life 
Technologies) according to the manufacturer’s protocol.  In brief, IVF and SCNT 
embryos were collected from a minimum of three separate IVF and SCNT production 
days and collected at the 8-cell and expanded blastocyst stages.  Embryos were fixed in 
PBS with 4% formaldehyde at room temperature for 30 min and then permeabilized in 
PBS with 1% Triton X-100 at room temperature for 30 min.  Embryos were then washed 
with PBST.  Embryos were incubated in the TdT reaction cocktail to incorporate EdUTP 
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into dsDNA breaks.  This was followed by incubation in Click-iT reaction cocktail to 
induce fluorescence of EdUTP.  For each TUNEL assay two stage-appropriate embryos 
were used as a positive control by incubation in DNase I prior to performing the TUNEL 
assay.  Additionally, two stage-appropriate IVF embryos were used as a negative control 
by incubation in the TdT reaction cocktail, but were withheld from Click-iT reaction 
cocktail.  Following cocktail incubation, embryos were incubated with Hoechst 33342 
and mounted to slides and imaged as described above.  All blastomere nuclei positive for 
DNA degradation were counted in each embryo and the total number of apoptotic nuclei 
were divided by the total number of imaged embryos at the 8-cell (IVF, N = 23; SCNT, N 
= 14) and blastocyst (IVF, N = 48; SCNT, N = 39) stages to determine the average 
number of apoptotic blastomeres.  A two-way ANOVA with Bonferroni post-hoc test for 
multiple comparisons was used to measure significance between stage-matched IVF and 
SCNT embryos. 
 
ROS Detection 
 ROS detection was carried out using the Image-iT LIVE Green Reactive Oxygen 
Species Detection Kit (Life Technologies) following the manufacturer’s instructions.  
Briefly, embryos were washed in PB1+ (phosphate-buffered saline with Ca2+ and Mg2+ 
with 5.55 mM glucose, 0.32 mM sodium pyruvate, and 3 mg/ml BSA).  Cells were 
labeled following manufacturer’s protocol.  Embryos were stained with Hoechst and 
mounted to slides and imaged as described above. 
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Quantitative Reverse Transcriptase PCR (qRT-PCR) 
Individual embryos were suspended in 3 µl H2O, snap frozen in liquid nitrogen, 
and frozen at -80ºC until reverse transcription.  A total of 12 individual embryos were 
analyzed at the 2-cell, 8-cell, morula and blastocyst stages for both IVF and SCNT 
embryos.  Reverse transcription was carried out using the Cellsdirect One-Step qRT-PCR 
Kit (Life Technologies) according to manufacturer’s protocol.  Complementary DNA 
samples were immediately processed using the Biomark 96.96 Dynamic Array (Fluidigm, 
San Francisco, CA) using SYBR Green.   
The delta-delta Ct method (Δ-ΔCt) was used for analysis of gene expression.  The 
average Ct value for the housekeeping genes ACTB and GAPDH was subtracted from the 
Ct value of the gene of interest to yield a ΔCt value.  Then, the average ΔCt value for 
each gene of interest for all embryos at each IVF stage was subtracted from the ΔCt of an 
individual embryo for each gene of interest to yield the Δ-ΔCt value.  These Δ-ΔCt 
values were then used to calculate the expression level for SCNT embryos relative to IVF 
embryos at each developmental stage.  A number of samples lacked a positive Ct value 
for certain genes.  In order to calculate fold change any sample lacking a Ct value was 
assigned a Ct value of 40, the number of maximum cycles run.  These assigned Ct values 
were used to generate fold change using the ∆-∆Ct method.  Following fold change, all 
samples with failed reads were removed for expression data and statistical analysis.  Any 
embryo that failed for the majority of PCR assays (i.e., no transcript detected for most 
genes in the array) or any PCR assay that failed in the majority of embryo samples (i.e., 
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no transcript for a PCR assay for most of the embryo samples, IVF or SCNT) was 
excluded from further analysis. 
 
Statistical Analyses 
We employed a two-way ANOVA with Bonferroni post-hoc test for multiple 
comparisons (GraphPad Prism v 5.0, La Jolla, CA) to determine whether expression of a 
given gene was significantly different in SCNT embryos compared to their stage-matched 
IVF counterparts and to determine whether or not apparent differences in relative 
expression of a given gene in SCNT and IVF embryos were consistent across all embryo 
stages.  A probability of P < 0.05 was considered significant. 
 
Results 
Gene Expression in Cloned Embryos 
Gene transcription levels were measured for several apoptosis-specific genes 
using the BioMark Dynamic Array (Fluidigm).  This method allowed the examination of 
relative gene expression levels for individual embryos.  Figure 4-1 summarizes the 
expression data for all genes included in the Fluidigm array.  An examination of 
expression patterns across individual embryos revealed high variability for nearly all 
genes assessed for both IVF and SCNT embryos.  The gene set for this array included 
transcripts involved in early embryo development, pluripotency factors, genome 
reprogramming, apoptosis, cell cycle arrest, and several imprinted genes.  For the 
purposes of this project, the analysis was focused on a subset of transcripts relevant to 
apoptosis and cell cycle arrest, as well as several pluripotency factors.  Normalized gene 
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expression data and results of statistical analyses for the entire gene set are available in 
Figures 4-1 and Table 4-1, respectively.   
Several genes relevant to the apoptosis pathway were frequently detected in 
SCNT embryos, but not expressed at measurable levels in IVF embryos.  BAX, BCL2, 
and P21WAF1/Cip1, all of which play a role in regulating apoptosis or cell cycle arrest, are 
elevated in SCNT embryos compared to their IVF counterparts, although at specific 
developmental stages (Fig. 4-2).  For example, BAX was expressed in 42%, 36%, or 58% 
of SCNT embryos at the 2-cell, 8-cell, and blastocyst stages, but not in morula SCNT 
embryos.  Alternatively, fewer IVF embryos were positive for BAX expression at these 
developmental stages.  Expression of BAX was comparatively higher in SCNT embryos 
than IVF at the 8-cell and blastocyst stages, although these differences were not 
statistically significant (Fig. 4-3, Table 2).  BCL2 is an anti-apoptosis protein that inhibits 
BAX, and the BCL2:BAX ratio is an important regulator of apoptosis.  The BCL2 
transcript was detected in most embryos examined (Fig. 4-2), and levels of BCL2 
expression were significantly elevated in cloned blastocysts compared to IVF 
counterparts (P < 0.0001 by two-way ANOVA) (Table 4-2 and Fig. 4-3). 
The P21WAF1/Cip1 transcript was commonly detected in SCNT embryos at the 2-
cell, 8-cell and blastocyst developmental stages, whereas this gene was infrequently 
detected in IVF embryos (Fig. 4-2).  The most marked difference in relative expression 
was observed at the 8-cell development stage, where all SCNT embryos expressed 
comparatively higher levels of P21WAF1/Cip1 than their IVF counter parts (P < 0.01, two-
way ANOVA, Table 4-2).  
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Additional genes involved in apoptosis that are more commonly expressed in 
SCNT embryos included IGF2R, CX43, and PEG3 (Fig. 4-4).  PEG3 and IGF2R were 
expressed at significantly higher levels in SCNT clones at the 2-cell or 8-cell stages 
respectively (P <0.01 and < 0.05, respectively, two-way ANOVA, Table 4-2).  CX43 
transcript was detected in cloned embryos more frequently than IVF embryos at early 
developmental stages; an overall significant difference between IVF and cloned embryos 
was evident (P < 0.05), although the apparent levels of gene expression were not 
statistically different for any particular stage of development (Table 4-2).  
Several genes that are involved in P53 activation or somatic cell genome 
reprogramming were also examined.  Although not detected in any 2-cell or morula stage 
embryos, C-MYC was expressed in 73% of SCNT 8-cell embryos compared to only 9% 
for their IVF counterparts, and this expression was significantly higher (P <0.05, two-
way ANOVA, Fig. 4-5, Table 4-2).  Similarly, LIN28 was more frequently expressed in 
cloned embryos compared to IVF (82% versus 9% for 8-cell; 50% versus 17% for 
blastocyst stage) (Fig. 4-5), expression levels were not significantly different between 
SCNT and IVF embryos at any of the developmental stages.  SOX2 transcript was 
detected in most embryos without any apparent differences between embryos types (Fig. 
4-5).  However, levels of SOX2 expression were significantly higher in morula stage 
clones compared to IVF embryos (P < 0.01, two-way ANOVA, Table 4-2). 
 Finally, expression of two genes that may function to alleviate apoptotic pressure 
in SCNT embryos was examined.  ETS2 can block activation of P53, and more SCNT 
embryos expressed ETS2 transcripts than did IVF embryos at the 8-cell and blastocyst 
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stages (Fig. 4-4); expression of ETS2 was significantly greater in blastocyst stage clones 
compared to IVF embryos (P < 0.05, two-way ANOVA, Table 4-2).  Additionally, 
although KLF4 was not detected in any IVF embryos, about half of the SCNT embryos at 
the 8-cell stage expressed this gene at detectable levels (P <0.0001, two-way ANOVA, 
Fig. 4-5, Table 4-2).   
 
Fluorescence Immunohistochemistry  
Fluorescence immunohistochemistry was employed to examine protein 
expression for active P53, phosphorylated CDK2, P21, and BAX proteins in 8-cell and 
blastocyst stage IVF and SCNT embryos.  The 8-cell stage was selected based upon the 
large number of genes that appeared differentially regulated at this critical developmental 
checkpoint; blastocyst stage embryos were assessed as this is the developmental stage at 
which embryos are evaluated prior to transfer for subsequent in vivo experiments. 
Activated P53 accumulated within SCNT embryos to a greater extent than in IVF 
embryos at both the 8-cell and blastocyst stages (Fig. 4-6).  Phosphorylated cyclin-
dependent kinase 2 (phospho-CDK2) is a marker of cell cycle arrest.  Immunostaining of 
phospho-CDK2 revealed higher levels in SCNT embryos at both the 8-cell and blastocyst 
stages (Fig. 4-6).  Likewise, expression of P21 and BAX proteins were elevated in SCNT 
embryos at 8-cell and blastocyst stages (Fig. 4-7).   
 
TUNEL Assay 
The TUNEL assay was used to identify apoptotic cells in 8-cell and blastocyst 
stage SCNT and IVF embryos.  Results of the TUNEL assay indicate that there is no 
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apparent difference in DNA degradation between IVF and SCNT embryos at the 8-cell 
stage (Fig. 4-8).  However, at the blastocyst stage, SCNT embryos have significantly 
more apoptotic nuclei than do IVF embryos (Fig. 4-8).  The mean number of apoptotic 
nuclei in IVF embryos was 3.9 in IVF compared to 6.8 in SCNT blastocysts.  TUNEL 
measures DNA degradation in late-stage apoptotic cells, and the elevated incidence of 
DNA degradation in SCNT blastocysts confirms our expression and protein analysis of 
apoptotic factors. 
 
ROS Detection 
Reactive oxidative species (ROS) is an activator of apoptosis and may possibly 
induce apoptosis during preimplantation development.  In order to determine if ROS was 
elevated in SCNT embryos and potentially responsible for activating apoptosis, we 
compared levels of ROS in SCNT and IVF embryos.  ROS levels were highly variable 
among embryos, with no apparent patterns distinctive for SCNT or IVF embryos (data 
not shown).   
 
Discussion 
To determine whether the P53 pathway is activated in bovine cloned pre-
implantation embryos, we compared gene and protein expression of key regulators of 
apoptosis, cell cycle progression and genome reprogramming in SCNT and IVF embryos.  
Herein, we report that a number of genes and proteins involved directly or indirectly in 
activation of P53 or subsequent cell cycle and apoptosis pathways are aberrantly 
expressed in SCNT embryos.  We also report that apoptosis is elevated in blastocyst stage 
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bovine clones compared to their IVF counterparts.  To our knowledge, this study is the 
first to employ the Fluidigm platform, which incorporates nanofluidics for nano-scale 
quantitative RT-PCR, to investigate gene expression in single bovine embryos.  Results 
of these PCR analyses reveal a high level of inter-embryo variability in gene expression, 
an important observation when considering that success of SCNT is dependent on a 
single, high quality embryo.  Collectively, the observations of this study point to the 
involvement of the P53 pathway in mediating apoptosis in SCNT embryos.   
Apoptosis plays a key role in preimplantation development and is likely necessary 
to ensure the overall quality of blastomeres by eliminating defective cells from the 
embryo (Brison and Schultz, 1997; Hardy, 1997).  Several studies have shown that 
apoptosis in SCNT embryos is elevated compared to embryos generated by IVF 
(Fahrudin et al., 2002; Hao et al., 2003; Jang et al., 2004; Gjorret et al., 2005; Im et al., 
2006; Kumar et al., 2007).  Additionally, SCNT embryos have a lower cell count 
compared to IVF embryos (Koo et al., 2000; Fahrudin et al., 2002; Gjorret et al., 2005; 
Terashita et al., 2011), which is likely the result of higher levels apoptosis in clones.  
Although apoptosis occurs in IVF embryos, it occurs at minimal levels, whereas 
apoptosis in cloned embryos increases throughout pre-implantation development (Hao et 
al., 2003).   
P53 expression was elevated in SCNT embryos compared to their IVF 
counterparts, and this elevated expression may account for the lower blastomere count in 
clones observed in other studies (Devreker and Hardy, 1997; Byrne et al., 1999; Hardy et 
al., 2001) as well as the increased DNA degradation we observed in SCNT blastocysts in 
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this study.  Although embryos with reduced cell counts are developmentally competent 
(Machaty et al., 1998), embryos with greater cell numbers are better prepared for 
implantation and developmental success (van Soom et al., 1997).  Loss of SCNT embryos 
after transfer to surrogates and low pregnancy rates may be a consequence of high rates 
of apoptosis and reduced blastomere number during the preimplantation stage (Fahrudin 
et al., 2002).  
P21WAF1/Cip1 is transcriptionally regulated by P53 and is responsible for cell cycle 
arrest (Brugarolas et al., 1999).  Upon transcriptional upregulation, P21 acts as an 
inhibitor of cyclin/CDK2 to block the progression of the cell cycle (Niculescu et al., 
1998).  Results of this study establish that P21WAF1/Cip1 is expressed in a majority of 
SCNT embryos at the 2-cell, 8-cell, and blastocyst stage as measured by gene expression 
and protein immunofluorescence.  As an additional measure of cell cycle arrest, we 
performed immunostaining of the phosphorylated form of CDK2, which is a regulator of 
cell cycle progression and is inhibited by phosphorylation (Morgan, 1995).  CDKs are a 
target of inhibition by P21 (Poon et al., 1996), and phospho-CDK2 is higher in apoptotic 
cells.  Our results indicate that phospho-CDK2 is prevalent in SCNT embryos, yet 
present at low levels in embryos produced via IVF.  These results further support the role 
of cell cycle arrest as a factor that likely influences developmental competence of SCNT-
derived embryos.  While several research groups have examined the apoptotic status of 
SCNT embryos using the TUNEL assay and blastomere morphological changes (Hao et 
al., 2003; Jang et al., 2004; Gjorret et al., 2005; Im et al., 2006), this study was the first to 
investigate P53 activation as the trigger for apoptosis in SCNT embryos.  Additionally, 
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cell cycle arrest cannot be detected using assays such as TUNEL.  Our findings suggest 
that cell cycle arrest should be included as a standard in assessing SCNT embryo 
viability, as cessation of cell replication likely has grave consequences for development 
of SCNT preimplantation embryos.  The arrested development of a blastomere at the 8-
cell stage may reduce the total number of cells capable of contributing to embryo 
development.  Indeed, the prior observations that SCNT embryo cell counts are 
comparatively low (Koo et al., 2000; Fahrudin et al., 2002; Gjorret et al., 2005; Terashita 
et al., 2011) may be the result of blastomere arrest at earlier embryo stages. 
In addition to analyzing genes related to apoptosis, we also investigated 
reprogramming factors that may activate P53-mediated apoptosis.  Overexpression of C-
MYC has been shown to lead to the activation of apoptosis (Eischen et al., 1999; 
Pelengaris et al., 2002; Zhao et al., 2008; Kawamura et al., 2009).  In this study, C-MYC 
was detected in a majority of 8-cell SCNT embryos, but in only a single IVF embryo.  C-
MYC may act as a trigger in activating apoptosis following SCNT.  LIN28 was originally 
characterized as a heterchronic gene in C. elegans that acts as a switch that controls the 
timing and developmental fate of cells (Moss et al., 1997).  LIN28 is a translational 
enhancer of C-MYC, and elevated levels of this gene, as observed in 8-cell clones, could 
contribute to the activation of P53-mediated apoptosis (West et al., 2009).  
Expression of the pluripotency factor SOX2 was elevated in 2-cell and morula 
stage SCNT embryos compared to their IVF counterparts.  This gene is critical during 
early embryo development and in somatic cell genome reprogramming (Takahashi et al., 
2007; Yu et al., 2007; Silva et al., 2009).  When expressed ectopically, SOX2 can induce 
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expression of p21WAF1/Cip1 via the P53 pathway (Kawamura et al., 2009).  Interestingly, in 
this study, the elevated expression of SOX2 appears to precede P21WAF1/Cip1 expression in 
latter developmental stages.  Although largely absent in most embryos examined, KLF4 
expression was detected in more than half of the 8-cell cloned embryos examined.  
Because this protein has been shown to induce P21WAF1/Cip1 in other studies (Zhang et al., 
2000; Chen et al., 2003; Rowland et al., 2005), it stands to reason that KLF4 may have 
contributed to the higher levels of p21WAF1/Cip1 expression also detected in 8-cell SCNT 
embryos in this study.  Interestingly, while KLF4 can upregulate P21WAF1/Cip1, it also 
functions as a repressor of P53 (Li et al., 2001; Rowland et al., 2005).  Expression of C-
MYC and KLF4 does not appear to be required for preimplantation development, as 
neither gene was detected with regular frequency in embryos produced via IVF.  Both 
genes are expressed primarily at the 8-cell stage, and expression varied widely among 
SCNT embryos.  It is possible that the activation of genes such as C-MYC, SOX2, KLF4, 
and LIN28 is a necessary step in donor cell reprogramming.  However, the upregulation 
of these genes in SCNT embryos may contribute to activation of P53-mediated apoptosis 
and cell cycle arrest.  
Our study also demonstrates that BAX protein expression is elevated in SCNT 
embryos at the 8-cell and blastocyst stages.  Melka et al. (2010) observed higher 
expression of BAX in low quality embryos and suggested that BAX could serve as a 
marker for embryo quality in bovine embryos.  BAX can be transcriptionally upregulated 
by P53 (Oltvai et al., 1993; Miyashita and Reed, 1995), or P53 can directly activate BAX 
in a transcription-independent manner (Schuler et al., 2000; Chipuk et al., 2005).  
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Whichever the mechanism, increased BAX expression is important for understanding 
SCNT embryo failure.  It is however, essential to interpret BAX expression in context of 
BCL2.  In bovine IVF development, embryos with high cytoplasmic fragmentation had 
elevated levels of BAX, whereas embryos with limited cytoplasmic fragmentation had 
low BAX and elevated BLC2 (McCurrach et al., 1997; Yang and Rajamahendran, 2002).  
BCL2 confers an anti-apoptotic response (Levine, 1997; Yang et al., 1997), but activated 
P53 can directly inhibit BCL2 to facilitate apoptosis (Wang et al., 1993; Chiou et al., 
1994; Marin et al., 1994; Froesch et al., 1999).  Analysis of BCL2 transcription indicates 
that the gene is expressed within all embryos at all stages, but a statistically significant 
upregulation occurs within SCNT embryos at the blastocyst stage.  BAX expression was 
observed in a subset of embryos and was more commonly expressed in SCNT embryos 
that IVF.  Aberrant expression of genes involved in apoptosis was predominant in 8-cell 
SCNT embryos, which could induce a compensatory response to this apoptotic pressure 
leading to elevated expression of BCL2 in blastocyst embryos as a mechanism to 
conserve blastomeres.  This response may account for the development of SCNT 
embryos to the blastocyst stage despite the presence of apoptosis inducing factors such as 
BAX.  Additionally, the ETS2 gene is capable of suppressing P53.  ETS2 acts as a 
proliferation factor that blocks apoptosis (Venanzoni et al., 1996; Sevilla et al., 1999).  
Indeed, the expression of ETS2, KLF4, and BCL2 in clones may explain why some SCNT 
embryos are able to proceed through development and successfully develop despite 
activation of the P53 pathway.   
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In this study, we also detected elevated expression of IGF2R, CX43, and PEG3 in 
a subset of SCNT embryos.  IGF2R knockdown mice are typified by overgrowth during 
fetal development and perinatal death (Lau et al., 1994; Wang et al., 1994).  Additionally, 
IGF2R has functions as a tumor suppressor, as loss of function mutations to this gene 
lead to tumor growth (De Souza et al., 1995; Hankins et al., 1996; Chappell et al., 1997; 
Ouyang et al., 1997; Piao et al., 1997; Wang et al., 1997; Xu et al., 1997; Yamada et al., 
1997).  During apoptosis, IGF2R acts as a death receptor through activation of 
mitochondrial-dependent apoptosis (Motyka et al., 2000).  IGF2R overexpression 
increases cell susceptibility to apoptosis (Kang et al., 1999).  Likewise CX43 contributes 
to apoptosis and is elevated in SCNT embryos.  CX43 is a component of gap junctions 
and has been implicated in apoptosis (Huang et al., 2001; Kameritsch et al., 2013) and 
cell cycle arrest (Zhang et al., 2003).  PEG3 facilitates the translocation of BAX to the 
mitochondria and participates in P53-mediated apoptosis (Deng and Wu, 2000).  PEG3 is 
expressed in all stages of embryo development, but is elevated in SCNT embryos at the 
2-cell and morula stages.  The elevated expression of IGF2R, CX43, and PEG3 further 
highlights apoptotic environment under which SCNT embryos develop.  Collectively, our 
observations point to a scenario in which SCNT embryos experience apoptotic pressure 
that may contribute to either activation of the programmed cell death pathway or cell 
cycle arrest.  A consequence of either cell response would be the under-representation of 
the embryo cell population, placing that embryo at a selective disadvantage for robust 
placentation and fetal maintenance. 
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 The TUNEL assay detects 3’-OH DNA strand breaks that occur during late-stage 
apoptosis (Gavrieli et al., 1992).  TUNEL assay has been previously used to assess 
embryo viability during preimplantation development (Brison and Schultz, 1997; Byrne 
et al., 1999; Matwee et al., 2000; Gjorret et al., 2003; Gjorret et al., 2005).  Earlier reports 
have shown that DNA fragmentation as measured by TUNEL is higher in SCNT embryos 
as compared to IVF (Fahrudin et al., 2002; Hao et al., 2003; Jang et al., 2004; Gjorret et 
al., 2005; Im et al., 2006), and our data is consistent with these findings.  We observed no 
difference between IVF and SCNT at the 8-cell stage, which is expected as apoptosis 
related genes are minimally present at the 2-cell stage and onset of activation of the P53 
pathway appears to occur at the 8-cell stage.   Because TUNEL measures late-stage 
apoptosis, onset of apoptosis would not be expected until later in development, as we 
observed in blastocyst SCNT embryos.  
The potential benefits of SCNT are currently hindered by the low success rate of 
the technique.  A clearer understanding of the pathways implicated in the poor 
development of SCNT embryos may yield important knowledge that can be leveraged to 
develop interventions to overcome embryonic failure and improve developmental rates of 
cloned animals.  Future studies should examine other downstream genes in the P53 
pathway in order to gain additional insight regarding the mechanisms responsible for 
triggering P53-mediated apoptosis.  We did not explore chromosomal aberrations within 
cloned embryos, which have been associated with reprogramming (Marion et al., 2009), 
and cannot rule out that increase apoptosis is the result of chromosomal anomalies.  
Inhibition of P53 during preimplantation development may give a developmental window 
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of opportunity in which blastomeres can proliferate and development of the embryo can 
occur prior to implantation. 
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Table 4-1.  Primers Used for qRT-PCR 
Gene Forward Primer Reverse Primer 
ACTB TTCCGCTGCCCTGAGGCTCT TGTGGACAGCGAGGCCAGGA 
BAX ACCAAGAAGCTGAGCGAGTGTC CGAAGGAAGTCCAATGTCCAGCC 
BCL2 TTCGCCGAGATGTCCAGTCAGC TTGACGCTCTCCACACACATGACC 
CDX2  ACTACGGCGGATACCATGTGGC TTCCGCATCCACTCGCACAG 
C-MYC  TAGTGGAAATACGGGCTTGC TTCTTCCAGATATCCTCGCTG 
CX43  AACCGCTCCTCTCTCGCCCA CTGGCTCTGCTGGAAGGCCG 
DNMT3A CTGAGAAGAAAGCCAAGGTGATCGC ATGACCCAACGAGTGCCTTCCG 
ELF5  ACAGGAGGAGTTCATGGAGGCG GTCAACCCGTTCCAAAATTCCG 
EOMES  CTCAAATTCCACCGCCACCAAAC TCATCTGGGTGTTGTTGTTGTTTGC 
ESRRB  TGCTCAACGCCATCCCCAAG GGTGGAGGCATGGCATACAGTTTG 
ETS2  TCCCTGCTTGCGGTTTTCCC CCCTGTCATGCCAAACCTCTGC 
G9A CAGCAGCAGGGCCTGAACCC CCCACTCCTCCAGGGACCCG 
GAPDH CACCTTCTGCCGATGCCCCC CACGTTGGGAGTGGGGACGC 
GATA6 ACCGTGGATGGCCTTGACTGAC CGAAGGGATGCGAGGCGTAG 
GNAS  TGCTGCTGGGTGCTGGAGAATC ACGCACCCCTTCATCCTCCC 
HDAC1  AAATTCTTACGCTCCATCCGCCC AATATCCCGTAGGTCCCCAGTTCC 
HDAC2  AGGGATATTGGTGCAGGAAAAGGC GGGAATCTCACAATCAAGGGCAAC 
IGF2R GCCAAGTCACAGACCCCGCC GTCGGGGAGCCCGTTGTGTG 
JARID2  TCCGTGGTCAGAAGAAAGGGTGG CATTGTTGGTGGCTGCTTTGACG 
KAT2B TTGAACAGCAGAACGGAGGGAGC CCTACCAGCCACATGAGCACCTTC 
KDM3A GCAAGGACAAGGAGCAGCAGAAAG GTGCAGGTTGAAGATGGTGGTGTC 
KDM5A  CTGAATGAGCTTGAGGCGATGACC TGGCGAAGTTTGGATGTCAGTGC 
KLF4 GGCCGCCTGCTCACGACTTT GTGGCCGTCCTTTTCCGGGG 
LIN28  AAACGCAGATCAAAGGGAGA TGCAGAAACGCAGATCAAAG 
MASH2  CCTCGTCGTCCCCTGGTCGT CTGGCTCGGTGGTGGCTTGG 
MDM2  GATGAAGATGATGAGGTGTATC CCCAACATCTGTTGCAGTGA 
P21WAF1/Cip1 GCCACAGGTGCCATGTCTG TCTCGGTGACAAAGTCGAAG 
PEG3 CGCCAAAGTCAGGGAGAG CTTAACTGCCAGGACACC 
RASGRF1 TTCCTGAGCATCGACTTCCT AGCTTGTTGTTCCCACT 
SOX2 GTGAACCAGCGCATGGACAG GTGCCCTGCTGAGAATAGGAC 
TEAD4 CCGCAGCCTTCCACAGTAAAATG ATGTCCACGGCTTCGAGGTAGG 
UBE3A ACTGAGGGCTGTGGAAATGAGGC TCTTGCTCCTTGCCCGTCCTTC 
ZIM2 AGCCAGAGATCCACACCAAG CGGAAGCAGCACTTCCTATG   
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Table 4-2.  Statistical Analysis of Gene Expression. 
 Two-way ANOVA  
Bonferroni post hoc tests 
comparing IVF vs. SCNT 
Gene Embryo type Stage Interaction  2-cell 8-cell Morula Blast. 
BAX 0.2828 0.1660 0.9309  ns ns ns ns 
BCL2 0.1664 <0.0001 <0.0001  ns ns ns **** 
CDX2 0.0008 0.9596 0.7664  ns ns ns ns 
C-MYC 0.6040 0.1570 0.0222  ns * ns ns 
CX43 0.0297 0.7419 0.8253  ns ns ns ns 
DNMT3A 0.0311 0.0131 0.0119  ns ** ns ns 
ELF5 <0.0001 0.0020 0.0019  **** ns ** ns 
EOMES 0.0233 <0.0001 0.0022  ns **** ns ns 
ESRRB 0.0844 0.6047 0.2943  ns ns ns ns 
ETS2 0.0323 0.0060 0.2611  ns ns ns * 
G9A 0.0393 0.0492 0.6920  ns ns ns ns 
GATA6 0.0044 0.0336 0.0006  ns ** *** ns 
GNAS 0.3710 0.0001 0.1090  ns ns ns ns 
HDAC1 0.8995 0.0338 0.6881  ns ns ns ns 
HDAC2 0.0016 <0.0001 0.0245  ns ns ** ns 
IGF2R 0.0873 0.0040 0.1380  ns * ns ns 
JARID2 0.8297 <0.0001 0.1254  ns ns ns ns 
KAT2B 0.9355 0.0001 0.8978  ns ns ns ns 
KDM3A 0.0122 0.0175 0.2170  ns ns ns * 
KDM5A 0.1368 0.0066 0.3187  ns ns ns ns 
KLF4 0.0216 0.0019 0.0019  ns **** ns ns 
LIN28 0.0498 0.9456 0.8495  ns ns ns ns 
MASH2 0.0172 0.4921 0.4740  ns ns ns ns 
MDM2 0.3576 0.0864 0.1530  ns ns ns ns 
P21WAF1/Cip1 <0.0001 0.1330 0.0820  ns ** ns ns 
PEG3 0.0092 <0.0001 0.0282  ** ns ns ns 
RASGFR 0.0352 0.1162 0.0006  ns **** ns ns 
SOX2 0.0021 0.0487 0.0494  ns ns ** ns 
TEAD4 0.0939 <0.0001 0.0430  ns ** ns ns 
UBE3A 0.3657 0.0109 0.3088  ns ns ns ns 
ZIM2 0.5831 0.0032 0.0292  ns * ns ns 
Note: Fold changes were calculated using the Δ-ΔCt method using the averaged values of 
GAPDH and ACTB as an internal control.  Individual fold changes for each IVF and SCNT 
embryos were measured against the mean IVF ΔCt at the corresponding embryo stage.  The 
maximum Ct value of 40 was assigned to all embryos negative for gene expression in order to 
calculate fold change.  Statistical analysis employed a two-way ANOVA with Bonferroni post-
hoc test for multiple comparisons to measure significance between stage-matched IVF and 
SCNT embryos (Bonferroni post-hoc tests comparing IVF vs. SCNT column) as well as across 
embryo stages for both IVF and SCNT samples (Two-way ANOVA column). *, P < 0.05; **, 
P  < 0.01; ***, P < 0.001; ****, P < 0.0001.  Additional analyses were performed using the 
Student’s t-test with Welch’s correction compared IVF to SCNT embryos at each 
developmental stage (not shown); results of those analyses confirmed those obtained by the 
ANOVA shown here.   
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Figure 4-1.  Heat map of all genes analyzed for expression analysis.  Each cell of the 
heat map represents the relative expression of individual SCNT embryos and IVF 
embryos normalized to the mean expression for IVF at each developmental stage.  The 
number of embryos included in the analyses is shown in parentheses.  Colors represent 
the log2 fold change for embryos positive for expression for each gene, with red 
indicating elevated expression and blue indicating low expression.  Cells colored gray 
represent embryos for which the corresponding transcript was not detected.  
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Figure 4-2.  Log2 fold change expression values of BAX, BCL2 and P21WAF1/Cip1.  
Open bars represent individual IVF embryos and solid bars represent individual SCNT 
embryos at the 2-cell, 8-cell, morula, and blastocyst stages.  Fold change was calculated 
using the Δ-ΔCt method using the averaged values of GAPDH and ACTB as an internal 
control as described in Materials and Methods.  Fold changes for individual IVF and 
SCNT embryos were calculated relative to the mean IVF ΔCt at the corresponding 
embryo stage.  For those embryos with no transcript detection, a maximum Ct value of 40 
was assigned in order to calculate the fold change.  The percentage of embryos for which 
the indicated transcript was detected is shown below each Figure (N = 10 to 12 embryos).   
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Figure 4-3.  Average log2 fold change expression values of BAX and BCL2.  Open 
bars represent individual IVF embryos and solid bars represent individual SCNT embryos 
at the 2-cell, 8-cell, morula, and blastocyst stages.  Fold change was calculated using the 
Δ-ΔCt method using the averaged values of GAPDH and ACTB as an internal control as 
described in Materials and Methods.  Fold changes for individual IVF and SCNT 
embryos were calculated relative to the mean IVF ΔCt at the corresponding embryo 
stage.  For those embryos with no transcript detection, a maximum Ct value of 40 was 
assigned in order to calculate the fold change (N = 10 to 12 embryos).   
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Figure 4-4.  Log2 fold change expression values of IGF2R, CX43, PEG3 and ETS2.  
(following page) Open bars represent individual IVF embryos and solid bars represent 
individual SCNT embryos at the 2-cell, 8-cell, morula, and blastocyst stages.  Fold 
change was calculated using the Δ-ΔCt method using the averaged values of GAPDH and 
ACTB as an internal control as described in Materials and Methods.  Fold changes for 
individual IVF and SCNT embryos were calculated relative to the mean IVF ΔCt at the 
corresponding embryo stage.  For those embryos with no transcript detection, a maximum 
Ct value of 40 was assigned in order to calculate the fold change.  The percentage of 
embryos for which the indicated transcript was detected is shown below each Figure (N = 
10 to 12 embryos).   
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Figure 4-5.  Log2 fold change expression values of C-MYC, LIN28, SOX2 and KLF4.  
(following page) Open bars represent individual IVF embryos and solid bars represent 
individual SCNT embryos at the 2-cell, 8-cell, morula, and blastocyst stages.  Fold 
change was calculated using the Δ-ΔCt method using the averaged values of GAPDH and 
ACTB as an internal control as described in Materials and Methods.  Fold changes for 
individual IVF and SCNT embryos were calculated relative to the mean IVF ΔCt at the 
corresponding embryo stage.  For those embryos with no transcript detection, a maximum 
Ct value of 40 was assigned in order to calculate the fold change.  The percentage of 
embryos for which the indicated transcript was detected is shown below each Figure (N = 
10 to 12 embryos).   
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Figure 4-6.  Representative immunofluorescence images for P53 and phosphorylated 
CDK2 in IVF and SCNT embryos.  Alexa Fluor 488 detection of P53 (green) and 
Alexa Fluor 594 detection of phosphorylated CDK2 (pCDK2, red) are shown in 8-cell 
and blastocyst stage embryos.  Nuclei were stained using Hoeschst (blue).  A merged 
image for all three fluorescence detection channels is shown.  Images are representative 
of 12 to 18 embryos.   
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Figure 4-7.  Representative immunofluorescence images for P21 and BAX in IVF 
and SCNT embryos.  Alexa Fluor 488 detection of P21 (green) and Alexa Fluor 594 
detection of BAX (red) are shown in 8-cell and blastocyst stage embryos.  Nuclei were 
stained using Hoeschst (blue).  A merged image for all three fluorescence detection 
channels is shown.  Images are representative of 12 to 18 embryos.   
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Figure 4-8.  Representative images and evaluation of apoptosis in SCNT and IVF 
embryos.  (A) Cells undergoing apoptosis in 8-cell and blastocyst stage embryos were 
detected by TUNEL assay with Alexa Fluor 594 (red).  Nuclei were stained using 
Hoeschst (blue).  A merged image for both fluorescence detection channels is shown.  
Images are representative of embryos at the 8-cell (IVF, N = 23; SCNT, N = 14) and 
blastocyst (IVF, N = 48; SCNT, N = 39) embryos.  (B) A bar graph indicates the average 
number of DNA fragmented nuclei per embryo at the 8-cell and blastocyst stages.  Open 
bars represent IVF embryos and solid bars represent SCNT embryos.  Data is expressed 
as mean and ± SEM.  *, P < 0.05 indicates statistically significant difference between 
IVF and SCNT groups according to two-way ANOVA with Bonferroni post-hoc test for 
multiple comparisons.  
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CHAPTER 5 
 
CONCLUSION 
 
Over the past two decades, researchers have focused intensely on the problems 
associated with SCNT in an effort to improve the success rate of the technique.  Several 
advances in the cloning procedure have been made, but have only led to modest 
improvements in success rates.  Despite these collective efforts, SCNT remains 
inefficient, and the potential benefits from generating cloned offspring remain unrealized. 
My dissertation research was concerned with determining the factors that affect 
SCNT embryo development.  One line of inquiry of my work characterized the degree of 
apoptosis in SCNT embryos to determine whether programmed cell death is responsible 
for reduced embryo cell number and clone failure.  We compared gene and protein 
expression of several genes involved in apoptosis in cloned embryos, as well as measured 
several factors that may play a role in activating apoptosis. Additionally, we assessed 
DNA degradation and confirmed that SCNT embryos have higher rates of apoptosis 
during preimplantation development.  Results of these studies indicate that SCNT 
embryos have higher rates of apoptosis at the late developmental stage.  These 
observations were confirmed by gene and protein expression of several apoptosis factors, 
including the apoptosis regulator P53, which was expressed at higher levels in SCNT 
embryos compared to embryos produced via IVF.  Our results also showed upregulation 
of several genes that likely trigger apoptosis within SCNT embryos, including C-MYC, 
LIN28, SOX2, and KLF4.  These findings help illuminate the cause of embryo failure and 
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may lead to interventions that increase the success rate for development of SCNT 
embryos by targeting the apoptosis pathway. 
A second line of inquiry of my research was to determine whether the methylation 
signatures of the developmental genes POU5F1, NANOG, and SOX2 were appropriately 
reprogrammed in SCNT embryos prior to implantation.  These genes are essential for 
early development, and the aberrant reprogramming of methylation patterns would likely 
lead to embryo degradation.  Using bisulfite sequencing, we measured the methylation 
status of CpG islands associated with each gene and compared SCNT embryos to IVF 
and donor cell samples.  We determined that specific CpG sites of all three genes were 
abnormally established prior to implantation.  The genes NANOG and SOX2 contained 
CpG sites that were more similar to those of the donor cell than patterns observed in IVF 
embryos.  POU5F1 also contained aberrant levels of methylation, but POU5F1 was 
hypomethylated relative to IVF embryos.  Our results suggest that genes essential for 
development are aberrantly methylated, which may affect embryo developmental 
success. 
One constraint of methylation studies is the limited data that can be obtained from 
experiments.  The technique of choice for methylation analysis uses sodium bisulfite, a 
chemical that alters the sequence of DNA.  Although the technique allows for single base 
pair analysis of a sequence of interest, sodium bisulfite degrades DNA and renders it 
unstable.  Because of the problem of degraded DNA, amplified regions must be short, 
thus limiting the amount of data that can be generated during sequencing.  These 
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problems are compounded when using preimplantation embryos as a source of DNA, as 
the low amount of starting material markedly limits the scope of experiments. 
As few as five years ago, analysis of methylation required expansion of DNA 
fragments in bacterial colonies, followed by pyrosequencing; at most, researchers would 
gather 80 to 100 sequences for analysis.  This limitation has recently been overcome with 
the advent of high-throughput sequencing technology.  Next generation sequencing is 
contributing to more robust experiments and generating data sufficient to draw 
conclusions regarding the targeting and maintenance of methylation patterns.  Such 
advances allow for more expansive data collection that can be applied to research 
questions involving cloned embryos.  Most research in the area of DNA methylation has 
focused on methylation associated with CpG islands, but advances in the scope of data 
collection allow for the study of methylation in non-CpG island regions, including 
intragenic DNA.  Knowledge of the methylation status of all CpG sites for the genome of 
a cloned embryo would facilitate a greater understanding of epigenetic reprogramming 
following SCNT.  
A second challenge in methylation studies is the limited understanding of the 
biological consequences of DNA methylation.  It is well understood that methylation of 
regions near transcriptional start sites is associated with transcriptional silencing, but the 
mechanism(s) directing the targeted methylation of specific genes or loci within a gene 
promoter region remain poorly understood.  While experiments may reveal the pattern of 
methylation levels associated with genes, the elucidation of apparent differences in 
methylation status remains difficult due to a lack of knowledge about the interpretation of 
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this methylation code by transcription regulators.  For example, do specific methylation 
sites direct activation of transcription or is regional methylation critical for a specific 
gene?  Is there a necessary threshold of CpG methylation frequency within a regulatory 
region? Without a better understanding of the mode of silencing following DNA 
methylation, interpretation of results is limited. 
In order to address some of these problems and to expand our knowledge 
regarding how methylation targets and maintains a patterns within cells, we characterized 
the methylation pattern of a pseudogene family in order to assess how the genome treats 
identical sequences of DNA.  We examined four pseudogenes derived form the LIN28 
gene, as well as methylation of the parent gene itself.  Results of these analyses showed 
that pseudogenes are not methylated with the same pattern as the parent gene, but rather 
maintain methylation levels specific to the region into which the pseudogene was 
inserted.  These findings indicate that methylation maintenance enzymes are targeted to 
different genomic regions within the cell, and may ultimately lead to greater insights 
regarding the methylation machinery. 
 The research reported in this dissertation has added to the body of knowledge of 
the mechanisms of methylation regulation and helps to answer the question of why SCNT 
embryos fail.  Understanding the role of apoptosis in SCNT development may lead to 
better procedures, culture conditions or treatments that will better enable embryos to 
develop following SCNT.  Targeted disruption of the apoptosis pathway may yield 
improvements in the cloning procedure. If apoptosis could be briefly abated during 
preimplantation development, SCNT implantation and birth rates may increase.  
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However, it is possible that apoptosis functions to selectively remove dysfunctional or 
damaged blastomeres from the developing embryo and that inhibition of this process 
could allow for the inappropriate expansion of aberrant cells.  Additionally, by 
characterizing the reprogramming inefficiencies of SCNT embryos, this work contributes 
to the body of knowledge of epigenetic regulation.  Identifying epigenetic factors that 
may be responsible for reduced embryo viability and introducing information that 
suggests how methylation occurs differently in different regions of DNA may reveal 
better procedures to partially reprogram donor cells prior to nuclear transfer.  Continued 
research based on these conclusions may lead to more effective procedures for SCNT and 
greater success of the technique. 
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Aston KI, LI GP, Hicks BA, Sessions BR, Davis AP, Winger QA, Rickords LF, 
Stevens JR, White KL. 2009. Global gene expression analysis of bovine somatic 
cell nuclear transfer blastocysts and cotyledons. Mol Repro Dev. 76(5):471-82.  
 
Sessions BR, Aston KI, Davis AP, Pate BJ, White KL. 2006. Effects of amino 
acid substitutions in and around the arginine-glycine-aspartic acid (RGD) 
sequence on fertilization and parthenogenetic development in mature bovine 
oocytes. Mol Reprod Dev. 73(5):651-7.  
 
 
Publications in Preparation 
Davis AP, Benninghoff AD, Sessions BR, Meng Q, Thomas AJ, White KL. (In 
preparation) DNA methylation reprogramming of the POU5F1, NANOG, SOX2 
and KLF4 genes following somatic cell nuclear transfer.  Mol Repro Dev  
 
Davis AP, Benninghoff AD, Sessions BR, Thomas AJ, White KL. (In 
preparation) DNA methylation of the Lin28 pseudogene family.  BMC Genomics  
 
Davis AP, Meng Q, Sessions BR, White KL, Benninghoff AD.  (In preparation)  
Activation of the P53 pathway following somatic cell nuclear transfer. 
Reproduction 
 
  
 Abstracts 
Davis AP, Benninghoff AD, Meng Q, Sessions BR, Thomas AJ, White KL. 
Activation of the P53 apoptosis Pathway following somatic cell nuclear transfer 
Presented at the ADVS Graduate Student Symposium. August 6, 2012. Logan, 
UT.  
 
Davis AP, White KL. Gene expression of P53 and MDM2 following somatic cell 
nuclear transfer. Presented at the Intermountain Graduate Research Symposium. 
March 31, 2010. Logan, UT.  
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Davis AP, Sessions BR, Meng Q, Innes E, Osborne B, White KL. Identification 
of methyl-specific DNA binding proteins of the bovine Nanog and POU5F1 
promoter regions using electrophoretic mobility shift assay. Presented at the 
American Society of Cell Biology 49th Annual Meeting. December 5-9 2009, San 
Diego, CA.  
 
Davis AP, Bayles AH, Davies C, Innes EW, Meng Q, Osborne B, Sessions BR, 
White KL. Bisulfite sequencing analysis of POU5F1, C-MYC, LIN28 and 
NANOG following bovine somatic cell nuclear transfer. Presented at the 
American Society of Cell Biology 48th Annual Meeting. December 13-17 2008, 
San Francisco, CA.  
 
 Invited Presentations 
Davis AP, White KL. Sodium bisulfite sequencing shows aberrant epigenetic 
reprogramming following somatic cell nuclear transfer. Presented at the Center 
for Integrated BioSystems Research Seminar. November 2008 Logan, UT. 
 
Davis AP, White KL. DNA methylation patterns of POU5F1 and NANOG in 
single in vitro fertilized embryos. Presented at the Center for Integrated 
BioSystems Research Seminar. October 2007 Logan, UT. 
 
 
 
 
 
